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Diagnosis and treatment of bloodstream infections (BSIs) and infective 
endocarditis (IE) remain a challenge to treating physicians. Determining the 
microorganisms responsible is of major importance. New microbiological methods 
have emerged in the diagnosis of these entities with blood cultures remaining as a 
cornerstone. Changing epidemiology of IE and its risk groups pose a challenge to 
their treatment. BSIs and IE both contribute to a major morbidity and mortality. 
Hence, optimal treatment of these entities is imperative. 
Study I evaluated the impact of new microbiological method, short incubation 
matrix assisted laser desorption/ionization time-of-flight mass spectrometry (si-
MALDI-TOF), on the antimicrobial treatment of BSIs caused by Pseudomonas 
aeruginosa, Enterococcus spp. and AmpC-producing Enterobacteriaceae when 
introduced into a routine clinical setting. Patients were treated at Helsinki 
University Hospital (HUS) between February 2014 and March 2015. In 69 episodes 
si-MALDI-TOF identified the causative agent and in 55 episodes conventional 
identification methods were used. Identification by si-MALDI-TOF lead to 12.8% 
increase in episodes in which patients received appropriate antimicrobial treatment 
within 48 hours after the blood culture draw, which was the primary endpoint. In 
BSIs caused by Enterococcus spp. (n=62) the observed increase in appropriate 
antimicrobial treatment was 22.4% (87.9% vs 65.5%, P=0.038). In a subgroup of 
patients with immunosuppression si-MALDI-TOF method was observed to offer a 
significant benefit. Implementation of si-MALDI-TOF into a routine clinical setting 
was associated with an increased proportion of patients with appropriate antibiotic 
treatment within 48 hours after blood culture draw, especially in case of 
enterococcal BSIs. 
Study II explored bacteremia in patients with complicated skin and skin 
structure infections (cSSSI) in a population-based study including 460 patients 
with cSSSI from Helsinki, Finland and Gothenburg, Sweden. Blood cultures were 
positive in nearly one-fourth of those 258 patients from whom they were obtained. 
Diabetes, symptom duration less than two days and higher CRP level were 
associated with more frequent blood culture sampling, whereas surgical wound 
infection and peripheral artery disease were associated with less frequent blood 
culture sampling. None of the factors associated with blood culture drawing were 
found to be associated with blood culture positivity. Alcohol abuse was the only 
distinct patient characteristic associated with blood culture positivity. Patients with 
bacteremia had antibiotic treatment streamlined more often compared to non-
bacteremic patients, which demonstrates a clear benefit of the information acquired 
from positive blood cultures. Given the high percentage of bacteremia amongst 
those from whom blood was cultured, difficulties in predicting patients with 
bacteremia and benefit of the information acquired from positive blood cultures, 
clinicians should order blood cultures from patients with cSSSI with low threshold. 
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Study III evaluated the impact of pre-operative antimicrobial treatment 
duration on the yield of valve cultures and bacterial 16S PCR obtained during 
surgery for IE and the diagnostic value of PCR. The study cohort included 87 
surgically treated IE patients from HUS between years 2011-2016 and from whom 
valve culture and PCR sample from resected endocardial material were obtained. 
None of the patients with preoperative antimicrobial treatment duration longer 
than two weeks had positive valve cultures. PCR positivity was 91% in those 
patients with antimicrobial treatment duration less than two weeks and 53% in 
those with more than two weeks. In PCR positive cases preoperative antimicrobial 
treatment duration was significantly shorter than in PCR negative cases. PCR 
sampling had a diagnostic impact in one-sixth of the cases. Pre-operative treatment 
duration was shown to have a negative effect on the yield of both valve cultures and 
PCR. PCR sampling had added diagnostic value, especially in blood culture 
negative cases. 
Study IV was a population-based study including all adult patients diagnosed 
with IE in Helsinki University Hospital Area between 2013 and 2017. The objective 
of this study was to describe the epidemiology, the spectrum of the microorganisms 
responsible for IE, clinical picture and the treatment and outcome of IE in the 
study region. Another objective was to determine the proportions of IE episodes 
according to the source of infection (i.e., mode of acquisition) and to define the 
characteristics of these groups and compare their differences. In all, 313 episodes of 
IE originating from 292 patients were included in the study cohort. Staphylococcus 
aureus was the leading cause accounting for one-third of the cases, followed by 
viridans group streptococci and Enterococcus spp. Equal proportions of 
community-acquired IE, health care-associated IE and drug use-related IE were 
observed, each accounting about for one-third of the cases. Distinct features of 
these entities were described and also different outcomes. Health care-associated 
IE was associated with more underlying diseases, prosthetic valve involvement, 
enterococcal etiology and higher mortality than community-acquired IE. 
Intravenous drug use-related IE was associated with more frequent right-sided and 
bilateral involvement, Staphylococcus aureus as etiology but no difference in 
mortality compared to community-acquired IE. High proportion of health care-
associated IE and intravenous drug use-related IE pose a challenge for treatment, 
but also an opportunity for selected preventive strategies. In areas with common 
drug use, concomitant IE may account for a substantial proportion of all IE 
episodes, equal to that of HAIE. 
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Bloodstream infections (BSIs) and infective endocarditis (IE) intrigue both 
clinicians and researchers for they are severe infections with high morbidity and 
mortality, and their diagnosis and treatment are a challenge. The cornerstone in 
the diagnosis is a blood culture and optimal antibiotic therapy is crucial in their 
treatment. Determining the microbiological etiology without a delay is of utmost 
importance (Ibrahim et al. 2000, Seifert 2009). Also, clinicians should be well 
informed of the current epidemiological situation and clinical profiles of these 
entities, especially of IE, in order to better treat and prevent them. 
Matrix assisted laser ionization/desorption time of flight (MALDI-TOF) 
mass spectrometry has changed the field in diagnostic microbiology, especially 
in BSIs, for it provides earlier information on the causative microorganisms 
compared to traditional methods (Drancourt 2010, Patel et al. 2013). Impact of 
MALDI-TOF method on management and outcome of BSIs has been studied 
with promising results, especially when combined with antimicrobial 
stewardship program (ASP) intervention. However, its impact is not fully 
determined, particularly when it is introduced to a routine clinical setting and 
when short incubation technique is used. 
The treating physician receives a variety of critical information from the 
positive blood cultures. However, blood cultures do not come without a cost and 
false-positive results are relatively common. When exactly should blood culture 
be obtained? Skin and skin structure infections (SSSIs) are traditionally 
considered to be seldom blood culture positive and blood culturing is only 
recommended in special circumstances (Stevens et al. 2014). A Finnish-Swedish 
study on complicated SSSIs (cSSSIs) found blood cultures to be positive at quite 
a high rate, challenging the traditional view (Jääskeläinen et al. 2016). Factors 
associated with blood culture drawing and blood culture positivity are, however, 
undetermined in cSSSI and possible benefit of information received from 
positive blood cultures is undefined in this clinical entity. 
Given the severity of IE and long intravenous antimicrobial treatment 
required in its treatment, determining the causative agent of IE is imperative. In 
case of blood culture-negativity, etiology may be resolved by serological testing 
or by valve cultures or polymerase chain reaction (PCR) from resected 
endocardial material if a patient is operatively treated (Fournier et al. 2010). 
PCR obtained during surgery has been shown to be useful in diagnostics of IE, 
especially if blood cultures are negative (Miller et al. 2016). However, the impact 
of the duration of pre-operative effective antimicrobial treatment on the yield of 
PCR is undetermined. 
The clinical entity of IE has changed during the past few decades (Wang et al. 
2018). Health care-associated infection has emerged and it accounts at least 
one-fourth of the cases contemporarily. Intravenous drug use (IDU) is a major 
risk factor for IE and in areas where IDU is prevalent IDU-related IE is of major 
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importance. As a consequence of the changes in epidemiology, Staphylococcus 
aureus is now the leading pathogen responsible for IE in developed world 
(Moreillon and Que 2004, Fowler et al. 2005). Much of the data on IE are 
derived from referral centers, thus population-based studies are warranted. 
Studies comparing clinical profiles of IE according to the mode of acquisition 
are limited in number, especially studies comparing all three: community-
acquired IE (CAIE), health care-associated IE (CAIE) and intravenous drug use-
related IE (IDUIE). Moreover, no recent studies exist on the epidemiology and 
clinical entity of IE in the Capital Region in Finland. 
This thesis work evaluates the clinical impact of microbiological methods: 
MALDI-TOF performed in BSIs and PCR applied on resected endocardial 
material from patients with IE. Clinical impact and utility of new 
microbiological methods are important to evaluate, in addition to their 
performance in microbiology laboratory. In this work, also the impact of 
duration of pre-operative antimicrobial treatment on the yield of both valve 
cultures and PCR is evaluated. This thesis also views blood culture positivity in 
patients with cSSSI. It determines factors associated with clinicians ordering 
blood cultures from patients with cSSSI and also factors associated with 
bacteremia in those patients. Finally, this thesis characterizes and compares 
different clinical entities of IE according to the mode of acquisition and 
determines their proportions of all IEs. The microbial spectrum of 
microorganisms responsible for IE, and the incidence, clinical characteristics 
and outcome of IE in the Capital Region of Finland is described.  
Review of the literature 
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2 REVIEW OF THE LITERATURE
2.1 BLOODSTREAM INFECTIONS
Bloodstream infections (BSIs) include infective endocarditis, catheter-related 
BSIs and primary BSIs or they can arise from a focal infection, e.g., from 
complicated skin and skin structure infection (Coburn et al. 2012).  
BSIs can be acquired from community or they can be health care-associated 
(Friedman et al. 2002). They contribute to a major morbidity, mortality and 
healthcare costs (Weinstein et al. 1997, Kilgore and Brosette 2008, Pien et al. 
2010, Goto and Al-Hasan 2013). 
2.1.1 INCIDENCE AND BURDEN OF DISEASE
 
Incidence of BSIs is considered to be increasing in Finland, as was shown in a 
population-based registry study: the incidence increased from 147 to 168 per 
100,000 person-years during the study period between 2004 and 2007 
(Skogberg et al. 2012). Derived from these data, an estimated nearly 8,700 BSI 
episodes and nearly 1,100 deaths occurred from BSI per year in Finland 
(Skogberg et al. 2012, Goto and Al-Hasan 2013). An increase in incidence rate of 
BSIs was also reported in a population-based study from Denmark and the 
reported incidence rate reached 166 per 100,000 person-years in 2006 (Sogaard 
et al. 2011). In Denmark, one-third of BSI episodes were hospital-acquired 
2002-2006 (Sogaard et al. 2011). Even higher incidence rate of 189 episodes per 
100,000 person-years was reported from Olmsted County, Minnesota (Uslan et 
al. 2007). 
In all, an estimated 1.2-1.4 million episodes of BSI occurred in year 2007 in 
Europe and BSI is estimated to be among top seven causes of death in many 
European countries and in North America (Goto and Hasan 2013). As the 
incidence of BSI increases with age (Uslan et al. 2007), the overall burden of BSI 
in developed countries is likely to increase due to aging of the population. 
In a prospective evaluation of nearly a thousand cases from two tertiary 
centers, mortality attributable to nosocomial BSI was higher (23%) compared to 
community-onset (10%) and overall crude mortality was 24% (Diekema et al. 
2003). A 30-day mortality in evaluation of 14,303 bacteremia episodes from 
Denmark 2002-2006 was 15.4% for community-acquired, 22.0% for health 
care-associated and 27.7% for nosocomial bacteremia (Sogaard et al. 2011). In 
addition, in a Finnish study including 33,473 BSI episodes, a 30-day case-
fatality rate of 13% was observed, one-third of which occurred within 2 days 
(Skogberg et al. 2012). A finding which, for its part, highlights the importance of 
early identification and treatment. 
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2.1.2 MANAGEMENT, SOURCE OF INFECTION AND MICROBIOLOGY
 
The cornerstones of the management of BSIs are fast identification of the 
causative organism and the source of infection (Ibrahim et al. 2000, Seifert 
2009). This approach enables timely administered optimal antibiotic therapy, 
which is a crucial factor for better outcome (Kollef 2008). 
According to a prospective study from two centers in USA and including 929 
episodes of BSI the two most common (culture confirmed) sources were 
catheter (26%) and genitourinary (16%) followed by gastrointestinal/biliary 
tract (12%), respiratory tract (8%) and skin or soft tissue (6%; Diekema et al. 
2003). Proportions were roughly similar between community-onset BSIs and 
nosocomial (i.e., hospital-acquired) BSIs (Diekema et al. 2003).  
In year 2017 approximately 17,000 bacteremias were recorded by National 
Institute of Health and Welfare in Finland (Table 1) and their number has 
increased steadily over the recent years (Jaakola et al. 2018). Escherichia coli 
has been the most common finding and the second has been Staphylococcus 
aureus (Table 1). Similarly, in a population-based study from Olmsted County, 
Minnesota E. coli was the most common finding, also followed by S. aureus 
(Uslan et al. 2007). The study also found clear differences between genders: E. 
coli BSI was more common in females whereas BSI caused by S. aureus and 
viridans group streptococci were more common in males. 
 
 
Table 1. Annual number of selected blood culture findings in Finland according to National                                  





Blood culture finding Year 2013 Year 2017 
 Age 15-64 years Age ≥ 65 Age 15-64 years Age ≥ 65 
Escherichia coli 951 2876 1174 4011 
Staphylococcus aureus 641 876 846 1348 
Viridans group streptococci 151 193 119 207 
Enterococcus faecalis  83 301 103 395 
Enterococcus faecium 97 209 80 203 
Pseudomonas aeruginosa 91 230 66 288 
Enterobacter spp. 90 188 98 214 
Serratia spp. 32 81 39 107 
Morganella morganii 18 30 16 48 
All bacteremias 4189 8084 5059 11548 
Review of the literature 
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2.1.3 DEFINITION AND DIAGNOSIS
 
Universal definition of BSI does not exist, but BSI is considered in a patient with 
symptoms and signs consistent with an infection and with blood cultures 
positive with an organism associated with infection (Laupland and Church 
2014). Bacteremia means presence of viable bacteria in bloodstream. It must be 
noted that BSI and bacteremia are not synonyms, although often used 
interchangeably. BSI also includes fungemia (i.e., presence of fungi in 
bloodstream) and another difference is that, although rarely, bacteremia may be 
transient and thus not representing an infection (Laupland and Church 2014). 
BSI is diagnosed by performing a blood culture, which is one of the most 
common microbiological tests performed and has remained the first and 
essential diagnostic tool for the detection of BSI (Lamy et al. 2016). Blood 
cultures were applied in microbial diagnostics as early as late 19th century, and 
infective endocarditis was among the first clinical entities targeted (Allerberger 
and Kern 2020).  
Blood for culturing is obtained from venipuncture using a single-needle 
technique. One blood culture (one set) contains one aerobic and one anaerobic 
bottle. Two blood cultures are usually recommended and they can be obtained 
without an interval (Dargére et al. 2014). The sensitivity of blood culturing to 
detect bacteria in blood is correlated with the amount of blood drawn (Li et al. 
1994). Of patients with bacteremia approximately 90% will show positive results 
after two sets of blood cultures and over 95% after three sets (Lee et al. 2007). 
In addition, two blood cultures are useful in interpretation of results in case of a 
possible contamination, i.e., whether a growth of coagulase-negative 
staphylococci represents a contamination or true bacteremia (Weinstein et al. 
1996). More than two cultures are seldom needed, but suspicion of endocarditis 
is an exception to this rule.  
Antibiotic treatment hampers the utility and the sensitivity of blood culture 
and should be started only after the blood culture draw (Lee et al. 2007). In a 
study including 325 patients with severe sepsis preantimicrobial blood cultures 
were positive in 31.4% patients and repeated blood cultures drawn 30 to 240 
minutes after initiation of antimicrobial therapy were positive in 19.4% 
(P<0.001) demonstrating the negative effect of antibiotic treatment on the yield 
of blood cultures (Cheng et al. 2019). Another study including septic patients 
demonstrated equal positivity rates in blood cultures taken within one hour 
before (24%) and in blood cultures taken within one hour after (23%) initiation 
of intravenous antibiotics and also a sharp decline in blood culture positivity 






2.1.4 RECOGNITION OF BACTERIA FROM POSITIVE BLOOD CULTURES, 
THE MALDI-TOF METHOD, AND CLINICIAN´S VIEW
 
In microbiology laboratory, blood culture specimens are incubated in an 
automated blood culture instrument, which continuously monitors the samples 
and signals if growth is detected. In most microbiological laboratories blood 
cultures are routinely incubated for 5-6 days. This incubation time is considered 
adequate for detecting most bacteria, including fastidious bacteria, e.g., 
Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella and Kingella spp. 
which are referred to as HACEK-group (Baron et al. 2005, Kirn et al. 2013). 
If blood culture bottles are positive (i.e., growth is detected in specimens) 
next step is Gram staining, which provides the first information that the 
clinicians receive. The gram stain results are very useful if interpreted correctly 
and can lead to changes in antibiotic therapy (Munson et al. 2003, Huttunen et 
al. 2016). In light of the Gram stain results the likely effectiveness of the empiric 
antibiotic treatment can preliminarily be evaluated and the possible site of 
infection is also hinted. Gram staining results in combination with clinical 
background information may shorten delay to effective antimicrobial therapy 
(Hautala et al. 2005).  
Simultaneously with Gram staining subcultures are also performed. These 
allow further identification and also susceptibility testing. Identification is 
usually done by standard protocols using biochemical identification. In most 
cases recognition of the causative organism to species level may require at least 
48 hours and final results with susceptibility results are at clinicians’ disposal 
within 48 – 72 hours (Patel et al. 2013). However, it may take longer if the 
organism grows slow in vitro or is difficult to recognise.  
Blood cultures have remained the most important and comprehensive 
method in detecting microbes causing BSIs and determining their susceptibility 
to antimicrobial agents, despite progress in molecular diagnostic testing (Kirn et 
al. 2013, Lamy et al. 2016). 
 
Molecular methods
When blood cultures show growth it is beneficial to recognise the organisms as 
fast as possible. Thus, molecular rapid diagnostic testing (mRDT) has gained 
field in the diagnosis of BSIs in the past decade (Sullivan et al. 2019). MRDT 
refers to tests such as polymerase chain reaction (PCR) and MALDI-TOF. 
Infectious Disease Society of America (IDSA) recommends the use of RDTs in 
addition to conventional culture of blood samples if combined with 
antimicrobial stewardship program (ASP) intervention (Barlam et al. 2016). A 
meta-analysis on the effect of mRDTs on clinical outcomes of BSIs found an 
association with mRDT and decreased time to effective therapy and length of 
stay, and in presence with an ASP also a decrease in mortality (Timbrook et al. 
2017). Other RDTs include nucleic-acid-based methods such as fluorescence in 
situ hybridization (FISH), microarrays and rapid PCR-based tests (Opota et al. 
2015a).  




MALDI-TOF has revolutionized the field in microbiology diagnostics (Bizzini 
and Greub 2010, Dranoncourt 2010, Patel et al. 2013). It has proven to be 
especially useful in the diagnostics of BSIs, in which fast recognition of the 
causative organism is of utmost importance (Patel et al. 2013).  
In MALDI-TOF method laser ionizes the clinical sample within the matrix. 
Then ionized molecules are funnelled through electrostatic field into a time-of-
flight mass analyser. Different sized molecules have different flying times, thus 
creating a mass spectrum. Resulted mass spectrum is compared with spectra in 
a reference database resulting in identification. This process is fast and takes 
only few minutes. (Drancourt 2010.) 
However, specimen from incubated positive blood culture bottles cannot 
directly be applied to mass spectrometry, but the microbes need to be purified 
prior to analysis. For this purpose different purification approaches are applied 
(Faron et al. 2017). In a labour and time-consuming MALDI-TOF technique 
bacteria are purified by centrifuging and lysis before the analysis (Vlek et al. 
2012). This method is hereby referred to as direct MALDI-TOF method. In 
another less laborious method a short incubation (si) on solid media is used to 
isolate bacteria from the content of the blood culture bottle. This method has 
been found to be both accurate and useful (Idelevich et al. 2014, Verroken et al. 
2015, Kohlmann et al. 2015). This method is hereby referred to as si-MALDI-
TOF method. 
Implementation of the MALDI-TOF method in microbiology laboratory 
routine has significantly shortened the time from blood culture draw to 
recognition of the causative organisms of BSI to species level (Idelevich et al. 
2014, Vlek et. al 2012). A systematic review concluded that MALDI-TOF 
identification was at least 24 hours faster than conventional methods (Dixon et 
al. 2015). In a study of 218 patients with bacteremia direct MALDI-TOF 
shortened the time to organism identification by 28.8 hours compared to 
traditional identification (16.4 hours vs 45.2 hours; Vlek et. al 2012). 
Introduction of MALDI-TOF identification led to 17 hours reduction in time to 
identification (from 73.5 h to 56.8 h) compared to conventional identification 
and further reduction of 15 hours after introduction of si-MALDI-TOF (56.8 h – 
41.3 h) in a study comparing these three different identification protocols 
(Delport et al. 2017).  
The diagnostic sensitivity of MALDI-TOF is reported to be 65-99% 
depending on the organism (i.e., better performance for gram-negative bacteria 
compared to gram-positive) and it is highly specific (Faron et al. 2017). In 
diagnostics, polymicrobial BSIs are not accurately detected by MALDI-TOF 
method (Clerc et al. 2013).  
The shortcoming of the currently routinely used MALDI-TOF techniques is 
the recognition of bacteria and yeast only to species level without any additional 
information on the susceptibility of the organism. For example, MALDI-TOF 
can identify a gram-positive coccus to be S. aureus, but does not provide 
  
19 
information on its susceptibility to methicillin. In a world of growing bacterial 
resistance, fast information also on possible resistance of the causative agent of 
BSI is increasingly important. To tackle this issue, new clinical applications of 
MALDI-TOF are being developed to detect antibiotic resistance and also strain 
type of bacteria (Oviano and Bou 2018, Idelevich and Becker 2019). 
 
Finally, molecular methods that can be applied directly to blood samples 
(without prior subculturing) are being developed (Peker et al. 2018). Such 
methods include direct PCR methods, T2 magnetic resonance based methods 
(especially for Candida spp.) and metagenomics (Peker et al. 2018).  
Although direct PCR method poses clear advantages (e.g., speed and 
detection of noncultivable organisms) over traditional blood cultures, it will only 
be supplementary to blood cultures now and in the near future (Opota et al. 
2015b). Disadvantages of direct molecular diagnostics on blood sample include: 
lack of full automation and defined workflow in microbiology laboratory, too 
high sensitivity and incapability of reliably detect multifactorial resistance 
mechanisms of bacteria (Opota et al. 2015b). 
Delays in the diagnostics of BSI and the workflow in the microbiology 
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Figure 1 Work flow in the diagnosis of bloodstream infection and determining the causative 
agent. Upper part of the chart represents time elapsing in the ER from patient 
presentation to blood culture draw (usually 3 to 12 h). Lower part of the chart displays 
time elapsing in the microbiology laboratory. aThis is the first information that clinician 
receives, 18–24 hours from blood culture draw; bIf short incubation MALDI-TOF is done, 
this is the next information that clinicians receives, 24–32 hours from blood culture 
draw; c48-72 hours from the blood culture draw. Hours are approximations. In HUSLAB 
short incubation MALDI-TOF is done if blood culture bottle flags positive between 8 











2.1.5 IMPORTANCE OF APPROPRIATE ANTIBIOTIC TREATMENT
 
Timely administered appropriate antibiotic treatment is crucial in the treatment 
of BSIs, for it can reduce morbidity and mortality (Leibovici et al. 1998, Ibrahim 
et al. 2000). Data derived from a prospective cohort study of 3414 patients 
hospitalized for BSI found longer hospitalization for survivors (11 vs 9 days, P < 
0.05) and higher in-hospital mortality rate (34% vs 20%, P=0.0001) with 
inappropriate versus appropriate empirical antimicrobial treatment (Leibovici 
et al. 1998). In a multicenter study of febrile hospitalized patients (n=295) 
inappropriate empiric antibiotic therapy was associated with increased length of 
hospitalization (at least 2 days) and mortality (20% vs 12%, P=o.oo1; Fraser et 
al. 2006). Inappropriate initial therapy was an independent risk factor for 
increased length of hospital stay and mortality. Similarly, in patients with cSSSI 
appropriate empiric antibiotic treatment led to more rapid clinical stability 
(Jääskeläinen et al. 2017).  
Moreover, time is of the essence, and the utmost importance of timely 
administration of effective antimicrobial therapy is shown and emphasized in 
septic patients (Ibrahim et al. 2000, Kumar et. al 2006). Delayed start of 
antibiotics was the most important individual variable associated with high 
mortality in a Finnish study including patients with septic shock (Varpula et al. 
2007).  
Of note, underlying disease is another important factor contributing to 
mortality, especially between one and three months after onset of infection, as 
was noted in a Finnish study including blood culture-positive septic patients 
(Rannikko et al. 2017). 
The benefit of timely and effective antibiotic treatment has been shown in 
the treatment of BSIs caused by Pseudomonas aeruginosa (Kang et al. 2003, 
Lodise et al. 2007) and Enterococcus spp. (Zasowski et al. 2016). In hospital-
onset enterococcal bacteremia a 3-fold increase in 30-day mortality was 
observed if receipt of appropriate antibiotic treatment was delayed over 48 
hours (Zasowski et. al 2016) and similarly in hospital-acquired Pseudomonas 
aeruginosa BSIs delay of appropriate antibiotic treatment over approximately 
48 hours increased 30-day mortality over two-fold (Lodise et. al 2007). 
Enterobacter spp., Serratia spp. and Morganella morganii are Amp-C 
producing Enterobacteriaceae, which usually are nosocomial isolates 
(Donnerberg 2010). Due to their inducible AmpC-gene they are in most cases 
resistant to ampicillin and 1st generation cephalosporins and frequently also to 
2nd and 3rd generation cephalosporins (Donnerberg 2010). Treatment failures 
occur with cephalosporin therapy, even if the isolate is susceptible in vitro 
(Harris and Ferguson 2012). 
Finally, initiation of an empiric antimicrobial treatment is fine art (Kim and 
Gallis 1989). It should be mastered well and education helps. As 428 BSI 
episodes were prospectively evaluated, empirical antibiotic treatment was 
appropriate in 78% for the episodes treated by infectious disease (ID) specialists 
and 54% for the others (P<0.001; Byl et al. 1999). After blood culture results 
Review of the literature 
22 
were available corresponding percentages were 97% vs 89% (P=0.008). 
Additionally, ID specialists used fewer broad-spectrum antimicrobials. Similar 
finding of higher rate of optimal empiric therapy associated with infectious 
disease service was noted in another study with also a significantly higher 
incidence of de-escalation of antimicrobial treatment after culture results 
(Fluckiger et al. 2000). 
2.1.6 CLINICAL IMPACT OF MALDI-TOF BASED TECHNIQUES
 
When a new microbiological method is adopted in microbiology laboratory, in 
addition to the evaluation of its performance and impact on laboratory 
diagnostics, also its impact on patient management and outcome along with 
cost-effectiveness should be examined (Doern 2014, McElvania TeKippe 2016).  
Combined with ASP intervention, MALDI-TOF method decreased the time to 
both effective and optimal antibiotic therapy and was associated with reduced 
30-day all-cause mortality (20% vs 13%, P=0.021), decreased length of intensive 
care unit (ICU) stay and recurrent bacteremia in univariate analysis in a pre-
post study including 501 patients with bacteremia or candidemia (Huang et. al 
2013). A cost-analysis performed using the data derived of patients included in 
the study by Huang and colleagues revealed that despite extra costs of 
implementing MALDI-TOF with ASP, it was cost-effective with approximately 
2500 dollars saved per BSI and reduced cost was mainly due to the shortened 
ICU-stay (Patel et al. 2016). Cost-effectiveness of MALDI-TOF method with ASP 
was observed in another study including gram-negative BSIs (Perez et al. 2013). 
A study including 202 episodes of gram-negative BSIs found reporting of 
MALDI-TOF results impact the empiric antibiotic treatment in one-third of the 
cases whereas reporting of the Gram stain results had an impact in one-fifth of 
the episodes (Clerc et al. 2013). This study included only patients with infectious 
disease (ID) consultation, lacked a control group and did not evaluate clinical 
outcome. It must be noted that independent impact of the MALDI-TOF method 
was not evaluated in the abovementioned studies. 
Impact of MALDI-TOF without mandatory ASP intervention or ID 
consultation is less certain, as one study showed that MALDI-TOF combined 
with ASP intervention led to more favourable outcomes than MALDI-TOF alone 
(Berganovic et al. 2017). Similarly, in a clinical setting without ASP, MALDI-
TOF had no benefit on patient management or outcomes (Jeon et al. 2018). 
However, a crossover study of 218 patients with BSI demonstrated that in 
routine clinical setting direct MALDI-TOF compared to conventional methods 
improved the appropriateness of antibiotic treatment within 24 hours of blood 
culture positivity (75% vs 64%, P=0.01; Vlek et. al 2012). Impact on other 
clinical outcomes was not evaluated. Another study evaluated the effect of direct 
MALDI-TOF when introduced to a pre-existing ASP setting and found its use to 
be associated with less frequent ICU admissions (23% vs 37%, P=0.02) and 
shorter duration of antibiotic treatment in case of contaminated blood cultures, 
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but had no effect on overall duration on antibiotic therapy or length of hospital 
stay (Osthoff et al. 2017). 
Impact of short incubation MALDI-TOF technique on clinical management 
and outcome of patients with BSI is less studied. One study found its use to lead 
to a modified treatment recommendation in half of the cases, but its impact on 
clinical outcomes was not further assessed and the study lacked a control group 
(Kohlman et al. 2015). A study from London, UK including oncology and 
transplant patients with BSI found short incubation MALDI-TOF identification 
to be associated with shorter hospital stay and bacteremia associated mortality 
risk (Delport et al. 2017). Recent study conducted in pre-post method without a 
change in ASP policy with almost two thousand bacteremic patients included, 
found that implementation of short incubation MALDI-TOF led to a decrease in 
ICU admissions, shortened hospital stay and in case of gram-negative 
bacteremias also to decreased mortality (20% versus 16%; Zadka et al. 2019). 
However, as the authors note: lack of detailed data on antibiotic treatment is a 
major limitation of the study. 
2.1.7 WHEN SHOULD A CLINICIAN ORDER BLOOD CULTURES?
 
First step in diagnosing a bloodstream infection is a decision by the clinician to 
order blood cultures. When exactly should this test be performed? Published 
guidelines do not clearly answer this question (Baron et al. 2013).  
Blood culturing is not inexpensive and it is subject to false positive results in 
case of a contamination, causing quandary with the treating physicians. In 
hospital setting false-positive blood cultures have been found to increase the 
length and the cost of hospital stay (Alahmadi et al. 2011). One study found true 
negative blood cultures (i.e., no growth of microorganisms) to be 15 times more 
common than false positive blood cultures, yet much more health-care cost was 
related to false positive cultures (Zwang and Albert 2006).  
On the other hand, BSI is a serious infection with marked mortality (Pien et 
al. 2010). This fact might prompt clinicians to order blood cultures liberally. 
One study indeed suggested that clinicians do overestimate the probability of 
bacteremia in their patients (Poses and Anthony 1991). In a three-center 
prospective study from France including 2314 adult patients with blood cultures 
sampled in emergency departments, 10.6% were positive for pathogens and 
2.4% for contaminants (Dargére et al. 2014). In an analysis of 17,697 blood 
culture results collected at Helsinki University Hospital, Meilahti region during 
year 2012, the positivity rate was 5.4% and contamination rate less than 1% 
(Kalanti et al. 2013, unpublished data).  
In suspicion of sepsis and septic shock, blood culturing is recommended by 
Surviving Sepsis Campaign (Levy et al. 2018). Blood culturing in this clinical 
scenario, and infective endocarditis, is feasible and is endorsed in other 
guidelines and reviews (Coburn et al 2012, Fabre et. 2020). In patients with 
severe sepsis, 31.4% of blood cultures were positive in one study (Cheng et al. 
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2019) and in IE blood culture positivity is over 85% (Cahill and Prendergast 
2016). 
Clinical scenarios with high pre-test probability of bacteremia (>50%) 
include: septic shock, meningitis, endovascular infections, discitis, native 
vertebral osteomyelitis, epidural abscess and nontraumatic native septic joints 
(Fabre et al. 2020). In these clinical scenarios blood culturing is always feasible. 
Fabre and colleagues suggest in their review that in other scenarios with lower 
probability of bacteremia, clinician should also take into account if culturing can 
be done from primary site of infection and if the results from blood cultures are 
likely to impact patient management when evaluating possible blood culture 
sampling (Fabre et al. 2020). 
Fever and leukocytosis alone should not prompt blood culturing without 
considering the pre-test probability (Coburn et al. 2012, Linsenmeyer et al. 
2016). One study including hospitalized medical patients found true positive 
rate of 3.6% of all blood cultures (Linsenmeyer et al 2016). The most common 
indications recorded by the treating physicians in the study were fever and 
leukocytosis, neither being highly predictive of bacteremia. A study including 
patients with clinical suspicion of bacteremia found CRP concentrations to be 
associated with bacteremia, but to have a limited role in bacteremia prediction 
model including white blood cell count parameters (Wyllie et al. 2015). A recent 
study found the sensitivity of another biomarker, procalcitonin, for bacteremia 
to be unacceptably low for a rule-out test (Goodlet et al. 2020). 
Several clinical prediction rules to predict bacteremia have been developed. 
In a study of 3901 patients from whom blood cultures were drawn in emergency 
room, Shapiro et al. developed a clinical decision rule suggesting when to order 
blood culturing in a patient suspected to have an infection (Shapiro et al. 2008). 
This rule consists of three major or 10 minor criteria. Major criteria include: 
suspicion of endocarditis, temperature over 39.4 °C or indwelling catheter; 
minor criteria includes classical signs of severe infection, e.g., systolic blood 
pressure under 90 mmHg and thrombocytopenia. If one major or two minor 
criteria are met, blood culturing is recommended.  
Systematic review found 15 validated models for predicting bacteremia and 
defining groups with low and high probability of bacteremia (Eliakim-Raz et al. 
2015). However, these studies were heterogeneous in patient populations and 
variables, and with limited external validation (Eliakim-Raz et al. 2015). 
Moreover, none of these were found to be implemented in clinical work, 
including the one by Shapiro and colleagues. 
A recent scoping review including 50 studies constructed an algorithm in an 
attempt to promote a wiser use of blood cultures, both initial and follow-up 
cultures (Fabre et al. 2020). This algorithm is based on pre-test probability of 
bacteremia in different clinical scenarios, as discussed above. As noted also in 





2.1.8 BLOOD CULTURE POSITIVITY IN SKIN AND SKIN STRUCTURE 
INFECTIONS
 
Skin and skin structure infections (SSSIs) are common infections encountered 
by physicians working in emergency departments and hospital wards (Raff et al. 
2016). Beta-hemolytic streptococci and Staphylococcus aureus are the two most 
common causative agents of SSSI with former predominating in non-purulent 
cellulitis (Karppelin et al. 2015).  
SSSI is classified as complicated (cSSSI) if it involves deep subcutaneous 
tissues or needs surgery (FDA 1998, Dryden 2010, Jääskeläinen et al. 2016). 
Thus cSSSI represent the more severe forms of SSSI. Also, presence of systemic 
signs of severe infection (e.g., hypotension), presence of comorbidities or a need 
for hospitalization can classify SSSI as complicated (Dryden 2010). The annual 
incidence of cSSSI in Helsinki was 9/100,000 in a population-based study 
between 2008 and 2011 (Jääskeläinen et al. 2016).  
Gram-positive bacteria are predominating etiological agents in patients with 
cSSSI, as in two studies including patients with cSSSI approximately two-thirds 
of microbial findings were gram-positive bacteria (Jenkins et al. 2010, Garau et 
al. 2013). In these two studies, staphylococci accounted for 65% and 49%, 
streptococci 40% and 14% and gram-negative bacteria 13% and 46% of 
microbiological findings, respectively (Jenkins et. al 2010, Garau et al. 2013).  
A population-based study from Finland and Sweden including patients with 
cSSSI found S. aureus (21%) and streptococci (16%) to be the two most 
commonly found pathogens in monomicrobial infections of microbiologically 
tested patients (Jääskeläinen et al. 2016).  
A diagnosis and treatment guideline for skin and soft tissue infections by 
Infectious Diseases Society of America (IDSA) does not routinely recommend 
obtaining blood cultures in typical case of cellulitis (Stevens et al. 2014). They do 
recommend it in case of malignancy, severe infection or in case of unusual 
predisposing factors (e.g., animal bite). A study of cellulitis patients with blood 
culture positivity less than 5% is cited in this context as a rationale for the 
recommendation (Perl et al. 1999). Similar recommendation against blood 
culturing is stated in a study including 476 hospitalized patients with 
uncomplicated cellulitis with a blood culture positivity rate of 4.8% and 
sampling rate 53% (Bauer et al. 2016). In a recent large study from the United 
States including patients hospitalized for uncomplicated SSSI with low acute 
severity of illness and specially excluding cSSSI, found blood culture positivity 
rate of only 3% (and contamination rate of 2%) with blood culturing rate 
approximately 80%, suggesting that routine blood culturing is of low value in 
uncomplicated SSSI (Sutton et al. 2020). 
Higher blood culture positivity rates in patients with SSSI, especially in more 
severe and complicated cases, have been reported, which challenge 
abovementioned recommendations. Bacteremia was found in 7.6% - 12% of 
patients subjected to blood culturing in patients with cSSSI (Jenkins et al. 2010, 
Garau et al. 2013). Both studies had similar blood culturing rate of 53%. In 
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addition, a study including patients with lower limb cellulitis reported that 19% 
of patients subjected to blood culture had them positive (Peralta et al. 2006). A 
study including hospitalized patients with SSSI found blood cultures positive in 
16% of the patients from whom blood culture sample was obtained (van Daalen 
et al. 2017). 
It must be noted that considerable variation between studies exists in blood 
culture positivity rates, probably due to differences is patient selection (e.g., 
severity of disease), amount of blood drawn and blood culture drawing rate. 
Indeed, the severity of SSSI affects the blood culture positivity rate, as a review 
found blood culture positivity rate of 4.8% in patients with erysipelas and a rate 
of 8% in patients with cellulitis, which involves deeper tissues than erysipelas 
(Gunderson and Martinello 2012). 
The benefit of the information acquired from positive blood cultures has 
been questioned, as blood culture results seldom affected the antibiotic 
treatment in patients with complicated cellulitis (Paolo et al. 2013). 
Additionally, in patients with uncomplicated cellulitis blood cultures were 
exclusively due to Streptococcal spp. and Staphylococcus aureus, which were 
organisms usually susceptible to empiric antibiotics (co-amoxicillin) used in the 
study, thus bacteremia had no impact on change of empiric regimen (Bauer et 
al. 2016). 
2.1.8.1 Microbiological findings from positive blood cultures
 
Streptococci were the most frequent finding in blood cultures in a study 
including patients with SSSI (van Daalen et al. 2017); in a review including 
patients with erysipelas and cellulitis (Gunderson and Moreillo 2012); in a study 
including patients with limb cellulitis (Peralta et al. 2006); and in a study 
including uncomplicated cellulitis (Bauer et al. 2016). S. aureus constituted 11-
25% of all bacteremias in these four studies. Interestingly, proportions of S. 
aureus were equal in patients with cellulitis and erysipelas (14%) in one review, 
challenging the traditional view of greater role of S. aureus in cellulitis 
(Gunderson and Moreillo 2012).  
In one study, even one-fourth of blood culture findings were due to gram-
negative bacteria (Peralta et al. 2006). In this study, information from blood 
cultures led to modification of ongoing antibiotic therapy in nearly half of the 
cases (half of these changes were de-escalations). 
In patients with cSSSI, however, S. aureus seems to predominate. In a large 
multicentre study from Europe including almost two thousand patients with 
cSSSI S. aureus was the most frequent finding in blood cultures and one-fourth 
of findings were gram-negative bacteria (Garau et al. 2013). In a cohort of 322 
hospitalized patients with cSSSI S. aureus was found in eight patients and beta-
hemolytic streptococci in two out of 13 blood culture positive patients (Jenkins 
et al. 2010). 
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2.1.8.2 Factors associated with blood culture sampling
 
A population-based study including patients with cSSSI reported that male 
gender and cellulitis associated with blood culture draw in univariate analysis 
(Jääskeläinen et al. 2016). This study included 460 patients with cSSSI from 
Helsinki, Finland and Gothenburg, Sweden. This is best to my knowledge the 
only study in this patient setting to study these factors.  
In a study including patients with less severe SSSIs, acute severe clinical 
condition prompted blood culture sampling (van Daalen et al. 2017) and in 
patients with erysipelas those subject to blood culture sampling were sicker and 
had more often diabetes (Bläckberg et al. 2015). Higher CRP has been shown to 
be associated with increased blood culture sampling in patients with erysipelas 
(Bläckberg et al. 2015) and uncomplicated cellulitis (Bauer et al. 2016). 
2.1.8.3 Factors associated with blood culture positivity
 
Only few studies have studied the association of patient characteristics or 
clinical findings (including laboratory results) with bacteremia in patients with 
SSSI and have not showed uniform results, as discussed in detail below. In 
addition, possible benefits of information gained from blood cultures are even 
less addressed, as noted above. 
In a study including patients with limb cellulitis risk factors for bacteremia in 
multivariate analysis were absence of previous antibiotic treatment, two or more 
comorbidities, length of illness less than two days and proximal limb 
involvement (Peralta et al. 2006). Similarly, in a study including patients with 
SSSI higher blood culture positivity was observed in patients with severe co-
morbidities compared to those without (van Daalen et al. 2017). Whereas, in 
patients with uncomplicated cellulitis alcoholism was the only distinct patient 
characteristic associated with bacteremia in multivariate analysis (Bauer et al. 
2016).  
Nonetheless, bacteremia in patients with SSSI is important to recognize 
because bacteremia is proposed to be associated with important outcome 
factors. In patients with cSSSI, when comparing bacteremic patients to the rest 
of the study group, bacteremia was associated with clinical failure and 
prolonged length of hospital stay (Jääskeläinen et al. 2016) as well as to later 
clinical stability (Jääskeläinen et al. 2017). Moreover, bacteremia was associated 
with longer duration of hospitalization in multivariate analysis also in patients 
with uncomplicated cellulitis (Bauer et al. 2016). 
Given the incidence of SSSI and prognostic factors associated with 
bacteremia, Lipsky and colleagues constructed a prediction model to help 
clinicians to identify patients at high risk for bacteremia (Lipsky et al. 2010). 
They used a large database of adults who needed hospitalization for acute SSSI 
in USA and found 11 independent predictors for bacteremia. In their material 
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half of the patients had blood cultured with a positivity rate of 12%. They 
observed a three times higher in-hospital mortality in bacteremic patients 
compared to patients without bacteremia. S. aureus was the most common 
finding with more than one-half of the blood culture isolates, and with 
methicillin resistant S. aureus (MRSA) composing more than one-third of these 
cases (Lipsky et al. 2010). Another prediction model was constructed by Lee and 
colleagues based on cohort of patients from tertiary centre in Taiwan including 
hospitalized patients with cellulitis (Lee et al. 2016). They found four 
independent factors associated with bacteremia and included them in their 
model. These factors were: age over 65 years; involvement of non-lower 
extremities; liver cirrhosis; and fulfilment of systemic inflammation response 
syndrome criteria. Neither of these models, however, has been widely 
implemented in clinical work. 
2.2 INFECTIVE ENDOCARDITIS
Since the days of Sir William Osler and his famous The Gulstonian Lectures, On 
malignant endocarditis (Osler 1885) where he first described the clinical entity 
of IE, clinicians´ battle against IE has come a long way and has had major 
victories (e.g., antibiotic treatment), but the adversary remains undefeated.  
Despite medical progress, IE still contributes to major morbidity and 
mortality and the diagnosis and the treatment of IE remain a challenge (Hoen 
and Duval 2013, Cahill and Prendergast 2016, Wang et al. 2018). The clinical 
entity of IE has changed over time and it keeps on evolving (Wang et al. 2018). 
In the days of Sir William Osler and through most of the 20th century IE was 
mostly streptococcal disease of dental origin in patients with mitral stenosis 
caused by rheumatic fever, but in developed countries health care-associated IE 
with different causative agents, Staphylococcus aureus as the most common, 
has emerged along with prosthetic valve endocarditis and intravenous drug use-
related IE (Moreillon and Que 2004, Murdoch et al. 2009). 
Consequently, clinicians must stay alert and repeated studies on the 
epidemiology, etiology and clinical picture of IE are warranted (Hoen et al. 
2002). 
2.2.1 DIAGNOSIS AND CLINICAL PICTURE 
 
Along with a well-informed clinician who knows when to suspect infective 
endocarditis, blood cultures and cardiac ultrasound are the cornerstones in the 
diagnosis of IE (Cahill and Prendergast 2016). Indeed, diagnosis of IE is based 
on demonstration of cardiac involvement and presence of causative 
microorganisms. Other imaging modalities, such as 18F-fluorodeoxyglucose 
positron emission tomography/computed tomography (PET-CT), 
echocardiogram-gated computed tomography angiography and magnetic 
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resonance imaging are complimentary to cardiac ultrasound. PET-CT has been 
shown to be especially useful in the diagnostic work-up of prosthetic valve 
endocarditis (de Camargo et al. 2020). 
Given the perplexity of the disease, modified Duke criteria are used as a 
structured ground on which to base the diagnosis of IE (Li et al. 2000). Most 
studies concerning IE reference to these criteria. European Society of Cardiology 
(ESC) also adopted modified Duke criteria in their guideline on IE, but with 
some alterations (Habib et al. 2015). ESC includes imaging studies (i.e., CT 
angiography and PET-CT) as major criteria. Diagnostic criteria of IE are shown 
in Table 2. 
Duke criteria, which were originally developed for research purposes, should 
not overthrow clinical judgement when considering the diagnosis of an 
individual patient (Cahill and Prendergast 2016, Holland et al. 2016).  
Clinical presentation of IE depends mostly on the causative agent, affected 
valve, possible septic emboli and host factors. Classical categorisation to acute, 
subacute and chronic IE is outdated due to changing profile of IE (Cahill and 
Prendergast 2016). Classification according to the source (i.e., mode of 
acquisition) of IE to community-acquired IE (CAIE) or health care-associated IE 
(HAIE) and the type of the affected valve (native or prosthetic) is more relevant 
and gives tools for empirical antibiotic treatment and other treatment 
considerations.  
Fever and elevated markers of inflammation are present in majority of cases 
(Murdoch et al. 2009, Selton-Suty et al. 2012). New or worsened pre-existing 
heart murmur is a valuable clinical sign. In some cases, first symptoms result 
from septic emboli (e.g., stroke). Overall, stroke as a complication of IE is found 
up to one-fifth of the IE patients and septic emboli to other sites in one-third 
(Murdoch et al. 2009, Selton-Suty et al. 2012). Immunological phenomena and 
other classic signs of IE, albeit classic textbook material, have become rare due 
to earlier presentation of the patients and better diagnostic methods (Murdoch 
et al. 2009).  
IE should be considered especially in patients with bacteremia known to be 
associated with IE. In S. aureus BSI IE occurs in such a high proportion that 
routine screening for IE is warranted (Thwaites et al. 2011). In a prospective 
study from Finland including 430 patients with S. aureus bacteremia, IE was 
found in 17% of cases (Ruotsalainen et al. 2006). Community-acquired 
enterococcal BSI, in the absence of a primary focus, is a major criterion in 
modified Duke criteria, highlighting the importance of consideration of IE in 
patients with enterococcal BSI (Li et al. 2000). In a prospective study including 
344 patients with E. faecalis bacteremia, systematic evaluation found definite IE 
in 26% of patients (Dahl et al. 2019). This study suggested consideration of 
routine screening for IE in patients with E. faecalis bacteremia. Risk factors for 
IE were: prosthetic valve, community-acquisition, persistent bacteremia, 
unknown portal of entry, monomicrobial bacteremia and immunosuppression 
(Dahl et al. 2019). 
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In a recent national registry study from Denmark, IE was found in 16.7% of 
patients with E. faecalis BSI, in 10.1% of patients with S. aureus BSI and in 7.1% 
of patients with Streptococcus spp. BSI, suggesting also routine screening for IE 
in bacteremias caused by these agents (Ostergaard et al. 2019). 
As noted, bacteremia is a precursor for IE. In a systematic search for portal 
of entry in a study including 318 IE patients, it was found in 74% of patients 
(Delahaye et al. 2016). Most frequent portal of entry was cutaneous (40% of 
identified portals of entry), second being oral or dental (29%). Interestingly, 
dental infection focus was more often involved than dental procedure (59% and 




Table 2. Diagnostic criteria of infective endocarditis.
 
Definite IE 
  One pathological criterion or 
  Two major criteria or  
  One major criterion and three minor criteria or  
  Five minor criteria fulfilled 
Possible IE 
  One major criterion and one minor criterion or 
  Three minor criteria fulfilled 
Rejected IE 
  Criteria for possible IE not met or firm alternative diagnosis or resolution of symptoms ≤ 4 days 
  or no sign of IE in pathological examination of valves (with antibiotic therapy ≤ 4 days) 
Pathological criteria 
  Microbes demonstrated by histological examination or culture from valves or septic embolus or 
  Pathological lesion consistent with vegetation or abscess present in histological examination showing 
  active endocarditis 
Major criteria 
  Microbiological evidence 
    Blood cultures positive with typical microbe causing IE or 
    Blood cultures persistently positive with microbe consistent with IE or  
    Single positive blood culture or serology positive for Coxiella burnetii 
  Evidence of endocardial involvement 
    Echocardiogram findings consistent with IE (e.g., vegetation) or 
    PET-CT showing activity adjacent to prosthetic valvea or 
    Paravalvular lesion detected in cardiac CTa 
Minor criteria 
    Predisposing heart condition or injection drug use 
    Fever more than 38 C 
    Vascular phenomena (e.g., septic emboli, intracranial hemorrhage, Janeway lesions) 
    Immunological phenomena (e.g., glomerulonephritis, rheumatoid factor, Osler nodes) 
    Microbial evidence: blood cultures positive with microbe consistent with IE, but not meeting the major 
    criteria or serological evidence of active infection with microbe consistent with IE 
Adapted from modified Duke criteria (Li et al. 2000) and ESC guidelines (Habib et al. 2015). Note: a These  




2.2.2 DETERMINING THE ETIOLOGY
 
Considering the challenges in the treatment of IE, antibiotic treatment should 
be as optimal as possible for better outcome. Thus, determination of the 
causative organism is imperative. The absence of etiology has been shown to be 
an independent predictor of in-hospital mortality (Díez-Villanueva et al. 2016).  
2.2.2.1 Blood culture
 
In more than 85% of cases, the etiology of IE is provided by blood cultures 
(Murdoch et al. 2009, Hoen and Duval 2013, Cahill and Prendergast 2016). 
Infective endocarditis is an infection of endocardium of the heart, mainly the 
valves. Thus, in IE bacteremia is continuous. Three sets of blood cultures are 
recommended with at least an hour interval between first and last draw 
(Baddour et al. 2015, Habib et al. 2015). In critically ill patients two sets are 
adequate because receipt of antibiotic therapy should not be delayed in this 
setting. An interval between the blood culture draws is not considered necessary 
in one review (Liesman et. al 2017). The most common reason for blood culture 
negativity is prior antibiotic treatment, in one study nearly two-thirds of blood 
culture negative IE cases had received antibiotics within seven days of culturing 
(Murdoch et al. 2009). Causative agents may also be fastidious, require special 
media in order to grow or be non-cultivable. 
2.2.2.2 Serology and PCR
 
Blood cultures are negative in 10-15% of IE cases (Hoen and Duval 2013). In 
blood culture-negative endocarditis etiology may be revealed by serological 
testing, by PCR from blood or by PCR and culture of resected endocardial 
material in patients who undergo valve surgery due to IE (Fournier et al. 2010).  
In case of blood culture negativity, ESC recommends, according to local 
epidemiology, serological testing for Coxiella burnetii, Bartonella spp., 
Legionella spp., Brucella spp., Mycoplasma spp. followed by specific PCR 
assays for Bartonella spp., T. whipplei and fungi from the blood (Habib et al. 
2015). Serology for C. burnetii, the etiologic agent of Q-fever, is one of the major 
criteria of modified Duke criteria and is considered most reliable of the serologic 
tests (Li et al. 2000, Baddour et al. 2015). Other serological tests lack proper 
validation and standardization. However, serologic testing for Bartonella spp. is 
found useful in clinical work and is recommended to use with C. burnetii in the 
diagnostic work-up of blood culture-negative IE (Liesman et al. 2017). 
Systematic serological testing provided an etiology in 8% of IE cases in a study 
including 427 IE cases (Raoult et al. 2005).  
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In a study including 177 patients with definite, culture-negative IE from 
Marseille, France broad spectrum PCR from blood detected pathogens in three 
patients (1.7%) and specific PCR from blood in 24 patients (13.5%; Fournier et 
al. 2017). The two PCR methods from blood were, however, sole providers of 
etiology only in 14 cases and both were significantly less sensitive in detecting 
the causative organisms of IE than serology or culture or PCR from valves. 
2.2.2.3 Microbial sampling of the resected endocardial material
 
Valve cultures 
Valve culturing is recommended for IE patients who undergo valve surgery 
(Habib et al. 2015). The rationale behind this recommendation is that valve 
culture is a major criterion in modified Duke criteria and also culture results 
guide the duration of antibiotic treatment (Li et al. 2000, Habib et al. 2015). A 
study of 94 surgically treated IE patients did not find valve culture positivity to 
influence short- or long-term outcome (Dessap et al. 2009).  
Valve cultures are not particularly sensitive in detecting the causative 
organism of IE and due to contamination they are subject to false positive 
results (Liesman et al. 2017). Sensitivity rates of 26%-44% have been reported 
(Miller et al. 2016, Peeters et al. 2017). Contamination rates between 13%-35% 
have been reported (Voldstedlund et al. 2008, Vondracek et al. 2011). 
 
PCR  
Broad-range PCR followed by sequencing is a sensitive method in detecting the 
causative organisms of IE from resected valve material (Gauduchon et al. 2003). 
In a study of 29 histologically confirmed IE cases, PCR was positive in 27 and 
contributed to the diagnosis and management in 6 cases (Gauduchon et al. 
2003). Several studies have shown the usefulness of the PCR method from 
resected endocardial material in establishing the etiological diagnosis in IE and 
in particular when blood cultures are negative (Bosshard et al. 2003, Lang et al. 
2004, Greub et al. 2005). In addition to those early works, in a study from 
Belgium including 120 surgically treated definite IE patients, the sensitivity of 
16S rRNA PCR to detect the causative agent from resected valve was 87% and 
had an added diagnostic value in one fifth of the cases (Peeters et al. 2017). 
Similarly, in a study of 68 patients PCR contributed to the microbial diagnosis 
in one-third of the patients and contributed to a clinical decision in one-sixth 
(Miller et al. 2016). A prospective study from Sweden including 57 patients 
undergoing heart surgery for IE and a control group (n=61) without IE, 
observed PCR to be positive in 44 (77%) of cases and valve cultures in 13 (23%) 
of cases in IE group (Vondracek et al. 2011). In the control group of the Swedish 
study, PCR was negative in all cases, but valve culture was positive in eight 
(Propionibacterium spp. in seven and Corynebacterium spp. in one) and all 
were ruled as contaminations.  
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Addition of the PCR method to the diagnostic criteria of IE has been 
proposed (Bosshard et al. 2003, Peeters et al. 2017). 
2.2.2.4 Impact of pre-operative antimicrobial treatment on the yield of 
valve cultures and PCR
 
Pre-operative antimicrobial treatment has been found to have a negative effect 
on valve cultures (Upton et al. 2005, Kotilainen et al. 2006, Voldstedlund et al 
2008, Dessap et al. 2009). One study, however, reported no effect (Peeters et al. 
2017). In a study by Upton et al. 131 episodes of streptococcal IE in which 
operation was performed during antimicrobial treatment were retrospectively 
reviewed. They found that only in one case valve culture was positive in patients 
with pre-operative antimicrobial treatment duration more than two weeks 
(Upton et al. 2005). In two studies the median (or mean) duration of pre-
operative antimicrobial treatment was significantly shorter in patients with 
valve cultures positive compared to those with valve culture negative (Kotilainen 
et al. 2006, Voldstedlund et al. 2008).  
In previous studies, the duration of pre-operative antimicrobial treatment 
had no effect on the yield of PCR from the resected valve (Rovery et al. 2005, 
Kotilainen et al. 2006, Voldstedlund et al. 2008, Peeters et al. 2017). In three 
studies the median (or mean) duration of pre-operative antibiotic treatment was 
similar in patients with PCR positivity and PCR negativity (Rovery et al. 2005, 
Kotilainen et al. 2006, Voldstedlund et al. 2008). In a study by Rovery et al. 
similar proportions of PCR positivity were observed in patients with pre-
operative antibiotic treatment duration of 15 days or shorter and in patients 
with antibiotic treatment longer than 15 days (Rovery et al. 2005). 
2.2.3 EPIDEMIOLOGY
 
Reported incidence rates of IE vary between studies (Ambrosioni et al. 2017, 
Cresti et al. 2017). This is due to differences between populations studied, but 
also due to changes in population and risk groups for IE over time. For example, 
injection drug use is a major risk for IE and thus changing proportion of persons 
who inject drugs (PWID) in population is reflected on incidence of IE. In 
addition, changes in antibiotic prophylaxis guidelines might have an impact on 
incidence (Dayer et al. 2015).  
In a population-based survey from France including 497 definite cases of IE 
the annual incidence of IE was 3.4 per 100,000 inhabitants (Selton-Suty et al. 
2012). A recent population-based registry study from Finland estimated the 
incidence rate of IE admissions to be 6.3/100,000 person-years (Ahtela et al. 
2019).  
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In a recent review, the overall incidence rate of IE was concluded to have 
been rather stable in recent years (Ambrosioni et al. 2017). However, studies 
evaluating the evolution of incidence over time show somewhat conflicting 
results; some report an increase in incidence while others do not. For example, a 
study from Spain reported an increase by 2% per year during the study period 
between 2003 and 2014 (Olmos et al. 2017) and a report from England also 
showed an increase (Dayer et al. 2015), whereas a study from states of California 
and New York, USA did not (Toyoda et. al 2017). In summary, results of the 
latest studies on trends in the incidence of IE in different regions and countries 
show that the incidence of IE is probably increasing (Delahaye and Duclos 
2017).  
Increasing incidence of IE is most obvious among the elderly people 
(Slipczuk et al. 2013, Cresti et al. 2017, Olmos et al. 2017, Cuervo et al. 2018). 
Additionally, three 1-year population-based studies carried out in years 1991, 
1999 and 2008 in same regions in France observed an increasing mean age of IE 
patients from 58 years to 62 years, whilst overall incidence of IE stayed the 
same (Duval et al. 2012). Similarly, an increase in age of patients with IE was 
noted in a study from South-western Finland between years 1980-2004 (Heiro 
et al. 2006). 
2.2.4 RISK FACTORS
 
Several risk factors for IE exist. More than half of IE cases occur in patients over 
sixty-years of age (Hill et al. 2007, Selton-Suty et al. 2012, Habib et al. 2019). 
This is probably due to aging of general population and accumulation of other 
risk factors (e.g., valvulopathy and increase of invasive diagnostic and 
therapeutic procedures) with age. Male predominance is observed in most 
studies with male-female ratio over 2:1 (Hill et al. 2007, Selton-Suty et al. 2012). 
Injection drug use is a major risk factor and is discussed separately (section 
2.2.7.2). Poor dental health is considered a risk factor for IE from oral 
streptococci (Lockhart et al. 2009). In addition, haemodialysis, diabetes, 
indwelling venous catheters and immunosuppression are risk factors for IE 
(Hoen and Duval 2013, Cahill et al. 2017). Moreover, variety of invasive non-
dental procedures has been proposed to be associated with risk of development 
of IE (e.g., cystoscopy and colonoscopy; Janszky et al. 2018). 
High cardiac risk factors include prosthetic valve, certain congenital heart 
diseases and previous IE, whereas rheumatic heart disease, degenerative valve 
disease, implantable cardiac devices (e.g., pacemaker) and hypertrophic 





2.2.5 MODE OF ACQUISITION
 
Defining the mode of acquisition of IE is important as the microbiological 
etiology and outcome, and to some extent also the clinical picture, differs 
according to it. IE can be acquired from community or it can be health care-
associated (Friedman et al. 2002). IE occurring in persons who inject drugs 
(PWID) is considered separately from these, since PWID are a major distinct 
risk group (Moss and Munt 2003). IE is considered to be community-acquired 
when IE develops before or within 48 hours of hospitalization in a patient not 
meeting the criteria for HAIE. 
2.2.5.1 Health care-associated IE (HAIE)
 
HAIE refers to an episode of IE that (1) develops 48 hours after hospital 
admission, (2) is acquired in association with recent hospitalization or invasive 
procedure or (3) occurs in patients with recent extensive contact with health 
care (e.g., wound care or hemodialysis) or (4) occurs in persons who reside in 
nursing homes (Friedman et al. 2002, Ben-Ami et al. 2004, Fernandez-Hidalgo 
et al. 2008).  
HAIE can be further classified to nosocomial (i.e., hospital-acquired) HAIE 
or non-nosocomial HAIE. Hospital-acquired IE has traditionally included IE 
episodes developed after 48 hours after admission or occurring 2-3 months after 
hospitalization with invasive procedure. In their work Ben-Ami et al. suggested 
broadening of this definition to include IE episodes arising within six months 
after hospitalization (Ben-Ami et al. 2004). Non-nosocomial HAIE includes 
patients with ambulatory invasive procedures done (e.g., urologic procedures, 
angiography) before the onset of IE (Fernandez-Hidalgo et al. 2008, Lomas et 
al. 2010), but can be extended to include also patients with extensive contact 
with health care (e.g., recent wound care or residence in a nursing home; 
Friedman et al. 2002). Clinical characteristics and outcome of nosocomial and 
non-nosocomial HIAE are similar (Benito et al. 2009). 
The reported share of HAIE of all IE cases varies between studies and 
depends on the definition of HAIE applied, study population and selection 
criteria (Table 3). Overall, HAIE is estimated to account for at least one-fourth 
of all IE cases (Table 3). In a large population epidemiology study including New 
York State and California HAIE accounted for more than half of the native valve 
IE (Toyoda et al. 2017).  
The incidence of HAIE is increasing, as was shown in Spanish study 
including IE patients from 1984 to 2007 (Lomas et al. 2010). The 
abovementioned study from USA showed an increase in HAIE likely acquired 
from outpatient health care and a decrease in HAIE likely acquired from 
hospital setting during the study period between years 1998-2013 (Toyoda et al. 
2017). Reasons for the increasing incidence of HAIE are manifold: diagnostics 
for IE are improved, the definition of HAIE is broadened and also more and 
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increasingly older people are subject to invasive procedures, both diagnostic and 
therapeutic. Microbiological etiology of HAIE in selected studies is shown in 
Table 3. 
HAIE has a higher mortality rate compared to CAIE (Fernandez-Hidalgo et 
al. 2008, Lomas et al. 2010, Selton-Suty et al. 2012). This is mostly due to 
higher rates of staphylococcal etiology and older patients with higher co-
morbidity. HAIE is also considered to be an independent predictor of death 
(Fernandez-Hidalgo et al. 2008, Benito et al. 2009, Lomas et al. 2010). 
Given the increasing incidence and high mortality rates of HAIE, preventive 
measures in health-care setting are of utmost importance (Benito et al. 2014). 
 
 
Table 3. Proportion of HAIE of all IE episodes and proportions of Staphylococcus aureus, 
viridans group streptococci and enterococci of all HAIE episodes in studies on IE.
Reference  




Proportion (%) of HAIE cases by 
etiology 
Proportion (%) 
of HAIE of all IE 
cases S. aureus VGS enterococci 




33.7 10.8 22.9 28.4 
Benito et al. 2009  
(n=1622) 
Multinationalb 45 8 15 34c 
Sy and Kritharides 2010 
(n=1536) 
Australiad 33 16 16 30 




30.7 2.4 17.3e 16f 
Selton-Suty et al. 2012 
(n=497) 
Franced 32.8 10.7 4.1 26.7 
Abbreviations: IE, Infective endocarditis; HAIE, Health care-associated IE; VGS, viridans group streptococci 
a Single referral center study 
b Multicenter study 
c Only native valve IEs with people who do not inject drugs included in the study 
d Population-based study 
e Enterococcus faecalis only 
f Only left-sided native valve IE included in the study 
 
2.2.5.2 Intravenous drug use-related IE (IDUEI)
  
Intravenous drug abuse is a major risk factor for IE and is also included as a 
minor criterion in modified Duke criteria (Li et al. 2000, Wang et al. 2018). 
Proposed factors predisposing PWID to IE, and particularly right-sided IE, 
include: endothelial damage to the tricuspid valve caused by substances 
injected, altered right-sided blood circulation circumstances (e.g., drug-induced 
pulmonary hypertension), injection of high load of bacteria or yeast 
concomitantly with drug injection (e.g., from skin or from the drug itself; 
Frontera et al. 2000). Also, if saliva is used to dilute the drug, oral bacteria or 
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yeast may be injected in vein. Methamphetamine has cardiac toxicity and 
negative effect on the immune system (Yu et al. 2003) and thus it may 
predispose to IE similarly to cocaine (Cooper et al. 2007). 
Incidence of IDUIE varies greatly between studies as noted in large review 
(Slipczuk et al. 2013). A population-based study from Spain reported a decrease 
in prevalence of IDUIE during the study period from 2003 to 2014 and overall 
prevalence less than 5% (Olmos et al. 2017) and in France prevalence of IDUIE 
remained stable and under 10% in three population-based surveys 1991, 1999 
and 2008 (Duval et al. 2012). Whereas a study from USA, where the opioid 
crisis is prevalent, report an increasing proportion of IDUIE of all IE cases: from 
27% in years 1999-2000 to 40% in years 2009-2010 in Kentucky (Seratnahaei et 
al. 2014). Similarly in a national registry-based study from USA IDUIE 
increased from 15% to 29% of all IE cases between 2010 and 2015 (Rudasill et 
al. 2019). A study from a Finnish teaching hospital between years 1980-2004 
and with 326 episodes of IE reported a significant increase of IDUIE up to 20% 
of cases during the last 5-year period (Heiro et al. 2006). 
Clinical entity of IDUIE differs from non-IDUIE in many aspects. Patients 
with IDUIE are younger with less co-morbidities (Ruotsalainen et al. 2006, 
Leahey et al. 2019, Rudasill et al. 2019). Staphylococcus aureus is clearly the 
most common causative agent (Sousa et al. 2012, Rodger et al. 2018, Leahey et 
al. 2019). In most studies, PWID with IE have right side affected more often 
than left side, whereas right-sided IE in general is less common, comprising 5-
10% of cases (Cahill and Prendergast 2016). Vast majority of right-sided IE 
cases occur in PWID.  
In a study including 202 cases of first-episode IE cases in PWID, right-sided 
infection was more common (61%) and S. aureus caused 77% of IE cases and no 
cases of HAIE were observed (Rodger et. al 2018). In a Finnish study right-side 
IE was observed in 60% of IDUIE cases caused by Staphylococcus aureus 
(Ruotsalainen et al. 2006). A study from single-center from Boston, USA 
compared IDUIE (103 patients) to non-IDUIE (278 patients) and found more 
frequent right-sided and both-sided valve involvement, history of previous IE, S. 
aureus as etiology and interestingly also operative treatment in IDUIE 
compared to non-IDUIE (Leahey et al. 2019). 
A reduced mortality of IDUIE compared to non-IDUIE at index 
hospitalization has been observed (6.8% vs 9.6%, P<0.001), probably due to 
younger age and more frequent right-side involvement (Rudasill et al. 2019). 
However, despite IDUIE patients having fewer comorbid diseases and younger 
age compared to non-IDUIE patients, no difference were observed in one-year 
all-cause mortality (16% vs 13%, P=0.58; Leahey et al. 2019). Left-sided IE in 
PWID is associated with worse prognosis (Thalme et al. 2007, Ortiz-Bautista et 
al. 2015). 
In the treatment of IDUIE concomitant treatment of addiction is in a key role 
and is associated with reduced mortality (Rosenthal et al. 2016, Rodger et al. 
2018). Multidisciplinary endocarditis teams might include also psychiatry and 
social services in the treatment of this complex entity (Yanagawa et al. 2018). 
Review of the literature 
38 
2.2.6 PROSTHETIC VALVE IE
 
In a review including only population-based observational studies, a significant 
increase in IE in patients with prosthetic valve was observed (Tleyjeh et al. 
2007). Risk of development of prosthetic valve IE (PVE) is highest during the 
initial three months after surgery and remains high during the 12 months after 
operation (Karchmer and Longworth 2002). The risk is estimated to be 1-5% 
during the first post-operative year and 1% annually after that (McDonald 
2009). Valve operation for IE during active infection increases the risk of 
developing early PVE (Piper et al. 2001). PVE is considered early if it occurs 
within one year after the operation and early PVE is also defined to be HAIE 
(Piper et al. 2001). Risk of early IE seems to be higher and risk of late IE lower 
for mechanical valves compared to bioprosthetic valves (Stanbridge et al. 1997, 
Piper et al. 2001). Causative agents of late PVE resemble those causing native 
valve IE, but during the first post-operative year staphylococci predominate 
(Stanbridge et al. 1997, Piper et al. 2001). In a recent large multicenter study 
30.1% of all IE patients had PVE and 9.9% intracardiac device-related IE (Habib 
et al. 2019). Proportions of PVE of all IE cases in selected studies on IE are 
presented in Table 4. 
2.2.7 CAUSATIVE MICROBES OF IE
 
The microbiology of IE depends on the mode of acquisition of IE and whether IE 
occurs in native or prosthetic valve.  
The emergence of Staphylococcus aureus as the leading causative organism 
of IE at the expense of viridans group streptococci has been reported in many 
studies and reviews (Fowler et al. 2005, Murdoch et al. 2009, Selton-Suty et al. 
2012, Slipczuk et al. 2013, Vogkou et al. 2016). However, the predominance of S. 
aureus is not supported in all studies (Cuervo et al. 2018). In population-based 
studies from Olmsted County, Minnesota viridans group remained as the 
leading cause in a study between years 1970-2000 (Tleyjeh et al. 2005), but was 
outnumbered by S. aureus in a study between 2007 and 2013 (DeSimone et al. 
2015). Similarly, S. aureus outnumbered viridans group streptococci during the 
study period 1980-2004 in a Finnish study and the cause of this shift was 
increased proportion of IDUIE (Heiro et al. 2006). 
A recent large prospective multi-center study observed a high frequency of 
enterococcal IE (16%; Habib et al. 2019). The percentage of enterococcal IE was, 
however, counted using blood culture-positive cases as denominator instead of 
the whole study group and blood culture-negative cases were surprisingly many 
(21%). A trend of increasing enterococcal IE was observed in a large review of IE 
studies (Slipczuk et al. 2013). Enterococcal IE is increasingly recognised as 
emerging and challenging clinical entity of IE (Pericás et al. 2020). 
Three most common groups responsible for IE in most studies are 
Staphylococcus aureus, viridans group streptococci and enterococci (Table 4). 
  
39 
Coagulase negative staphylococci (CoNS) constitute approximately 10% of all 
IE cases (Murdoch et al. 2009). The role of CoNS as causative agents is greater 
in PVE, as 16% of PVE cases were due to CoNS in large multicenter study after 
excluding PWID (Chu et al. 2009). 
The HACEK group constitutes less than 5% of all IEs (Murdoch et al. 2009). 
The HACEK group refers to certain gram-negative bacteria and they were 
classically categorized to blood culture-negative IEs because they were difficult 
to cultivate but this is no longer the case (see also subsection 2.1.2). 
Rare of all IEs, but common causes of blood culture-negative IEs, are 
Bartonella spp., Coxiella burnetii and Tropheryma whipplei. A rigorous 
diagnostic approach revealed an etiology in 63% of blood culture-negative IEs in 
a French referral center (Fournier et al. 2010). Out of 476 cases with identified 
causative agent, 229 were C. burnetii, 85 Bartonella spp. and 12 T. whipplei. 
 
 
Table 4. Proportions of Staphylococcus aureus, viridans group streptococci (VGS) and  
enterococci as an etiology of IE of all IE cases in studies on IE. Proportion of PVE of 
all IE cases is also shown.
Reference Country / 
Region 
Inclusion criteria 
and number of 
cases included 
(number) 
Proportion (%) of all IE 
cases by etiology 
Proportion 
of PVE of 






Heiro et al. 2006 Turku, 
Finland 
Definite and 
possible IE (326)a 
33 20 6b 16 
Murdoch et al. 2008 Multi-center 
and -national 
Definite IE (2781) 31 17 10 21 
Sy and Kritharides 2010c Australia ICD-10 code 
(1536) 
32 23d 9 13 
Selton-Suty et al. 2012c France Definite IE (497) 26.6 18.7e 10.5 20.9 
Jordal et al. 2018 Western 
Norway 
All episodes (439) 31.4 22.5 13.0 31.0 
Cuomo et al. 2018 Spain Left-sided IE, 
PWID excluded 
(595)f 
18.5 24.4 15.6 36.3 
Abbreviations: IE, Infective endocarditis; PVE, Prosthetic valve endocarditis; VGS, Viridans group streptococci 
a Proportions presented are from the last five-year period in the study (2000-2004) including 96 episodes 
b Enterococcus faecalis only 
c Population-based study 
d All streptococci, VGS not specified in study 
e Oral streptococci 
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2.2.8 TREATMENT AND OUTCOME
 
Treatment of IE is multidisciplinary. Treatment consists of prolonged 
intravenous antimicrobial therapy, management of complications and surgery if 
necessary (Cahill and Prendergast 2016).  
 
Antimicrobial treatment
Antimicrobial treatment of IE is intravenous and preferably bactericidal (Habib 
et al. 2015). Recent study, however, showed promising results with oral 
antibiotics after initial intravenous course in selected patients (Iversen et al. 
2019). The duration and the need for possible combination therapy depend on 
the causative pathogen and its susceptibility (and minimum inhibitory 
concentration rate) and whether the valve is native or prosthetic.  
In Helsinki University Hospital (HUS) pathogen specific treatment follows 
ESC guidelines (Habib et al. 2015, Martelius et al. 2016; Table 5). In PVE caused 
by staphylococci, combination therapy including cloxacillin or vancomycin 
(depending on the susceptibility of staphylococci), gentamycin and rifampicin is 
recommended, whereas non-staphylococcal PVE treatment is recommended as 
for NVE, but with minimum duration of six weeks (Habib et al. 2015, Martelius 
et al. 2016). Possible allergies and kidney function should be taken into account 
when considering the treatment. 
Recommendations for empirical treatment differ. HUS guideline 
recommends, in case of NVE and late onset PVE, 2nd generation cephalosporin 
with addition of vancomycin in septic cases (Martelius et al. 2016), whereas ESC 
recommends ampicillin plus cloxacillin plus gentamycin in community-acquired 
NVE and late onset PVE and vancomycin plus gentamycin plus rifampicin in 























Table 5. Pathogen-specific treatment of the common causative agents of native valve 
IE according to HUS antimicrobial guideline (Martelius et al. 2016).
Pathogen Recommended first line regimen Duration 
(weeks) 
Staphylococcus aureus (MSSA) Cloxacillin  4-6  
Staphylococcus aureus (MRSA)1 Vancomycin 4-6  
Viridans group streptococci 
















Enterococci Ampicillin + gentamycin or 
Ampicillin + ceftriaxone or 




Abbreviations: MSSA, methicillin susceptible S. aureus; MRSA, methicillin resistant S. aureus; MIC, 
minimum inhibitory concentration 
1 also methicillin-resistant coagulase negative staphylococci 





Approximately one-fourth to one-half of the patients with IE needs surgery 
during the acute phase of infection (Prendergast and Tornos 2010). In the 
treatment of IE surgery is needed in cases of heart failure due to valvular 
dysfunction (or hemodynamic problems), uncontrollable infection (e.g., abscess 
or fistula formation or persistent bacteremia) or prevention of systemic emboli 
(Habib et al. 2015).  
In a large international, observational study, high mortality was observed in 
IE patients with indication for surgery, but who were treated conservatively 
(Habib et al. 2019). PWID have about 10 times higher hazard of death or 
reoperation compared to non-PWID between 3 and 6 months after operation for 
IE (Shrestha et al. 2015) and optimal use of surgery in PWID with IE is still 
somewhat unclear (Wang et al. 2018). A recent large meta-analysis found no 
difference in postoperative 30-day or in-hospital mortality between patients 
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Outcome
A large multicenter study including 2781 patients with IE (study period 2000-
20005) reported an in-hospital mortality rate of 18% (Murdoch et al. 2009). 
Compared to a more recent similar large multicenter study of 3116 patients 
(study period 2016-2018) mortality was not substantially decreased, for the 
reported in-hospital mortality rate was 17% (Habib et al. 2019). In addition, in-
hospital mortality rates of 20% and 23% were reported in population-based 
studies from Spain and France, respectively (Selton-Suty et al. 2012, Olmos et 
al. 2017) and a rate of 17% in a register study from Germany with case-fatality 
rate remaining constant during the study period 2005-2014 (Keller et al. 2017). 
In a Finnish register study a 30-day mortality after IE admission was 11.3% 
(Ahtela et al. 2019). Reported long-term mortality rates after IE diagnosis are 
higher: 22% within 6 months (Hill et al. 2006), 24% within 3 months (Toyoda et 
al. 2017) and 37% within one year (Toyoda et al. 2017). The observations of 
stable mortality rate are in keeping with other studies and clearly demonstrate a 
paradox: despite medical progress, mortality of IE remains high and is not 
decreasing. Some have even reported an increase in mortality (Cresti et al. 
2017). 
In-hospital mortality of IE has been shown to be associated with S. aureus 
infection (Murdoch et al. 2009). A large prospective multinational study found 
age, hemodialysis, hospital-acquired infection, prosthetic valve, S. aureus 
infection and IE complications, such as heart failure, persistent bacteremia and 
stroke to be strongly associated with 6-month mortality (Park et al. 2016). 
Viridans streptococcal etiology was associated with lower mortality and also, 
surgery during index hospitalization, but it was performed less frequently in low 
risk patients (Park et al. 2016). Risk of long-term major adverse events 
including ischemic stroke, hemorrhagic stroke, myocardial infarction, 
readmission for heart failure, sudden death or ventricular arrhythmia and all-
cause death are increased in patients who survive an episode of IE (Shih et al. 
2014). In a Swedish nationwide study long-term relative mortality risk after IE 
remained elevated up to five years and excluding the first year, the long-term 




Patients are at risk of repeat IE after the first episode of IE (Chu et al. 2005). 
Haemodialysis, IDU and a history of previous IE were found to be independent 
risk factors for repeat IE in a large multinational cohort of IE patients (Alagna et 
al. 2014). Indeed, PWID are at high risk of repeat IE after the first episode, as 
was demonstrated in a study in which 25% of PWID who survived the first IE 
episode developed a repeat episode after the initial IE episode with most repeat 
IE episodes being re-infections (86.4%) rather than relapses and occurring 
within one year after the initial IE episode (77.3%; Huang et al. 2018). 
Furthermore, all of the patients with repeat IE acknowledged a relapse of 
intravenous drug use (Huang et al. 2018). In another study including 212 first-
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episode IE cases in PWID, 32.1% developed a repeat episode, which was 
significantly more frequent compared to non-PWID (32.1% vs 6.2%, P<0.001; 
Rodger et al. 2019). A study from Boston, USA including 102 patients with IDU-
IE observed high rates of readmissions and recurrences and suboptimal 
addiction interventions (Rosenthal et al. 2016). 
2.2.9 CHANGING CLINICAL PICTURE OF IE
 
Is the clinical picture of IE changing? Based on the studies reviewed above, it is 
safe to say: yes. But, more precise answer is more complex. Results of IE studies 
depend on several factors. Studies from single referral centers tend to include 
more severe and complex cases of IE, thus influencing the characterization of IE 
and probably overestimating for example surgery rates, proportion of PVE and 
thus might show poorer outcomes. As in a population-based study from 
Rochester, USA only 20% of patients from Olmsted County needed operation 
for IE during the study period 2007-2013 whereas 44% of non-Olmsted County 
residents treated at Mayo Clinic, Rochester were operated (DeSimone et al. 
2015). On the other hand, population-based studies depend on the population 
being studied and results might not be generalizable outside the study 
population, as demonstrated by studies from Spain and Kentucky, USA with 
staggering differences in prevalence of IDUIE and even in an estimate whether 
incidence is increasing or not (Seratnahaei et al. 2014, Olmos et al. 2017). In 
addition, studies differ in selection criteria and diagnostic criteria used. For 
example, studies including only left-sided IE leave major proportion of PWID 
out. Also, definitions may vary (e.g., definition of HAIE). Major part of data on 
IE is derived from studies conducted in referral centers leaving population-
based studies in minority (Slipczuk et al. 2013). 
From the vast literature on the epidemiology of IE, few conclusions can be 
drawn. First, the incidence of IE is not decreasing. Second, in a population 
excluding PWID incidence in the elderly is increasing. Thirdly, proportion and 
importance of HAIE is increasing. Fourthly, Staphylococcus aureus as a 
causative agent dominates. Fifthly, repeated studies on IE are warranted to keep 
up with the old foe – and studies should preferably be of population-based 
nature. 
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3 AIMS OF THE STUDY
Objectives of this study were: 
 
1. To determine the impact of short incubation MALDI-TOF MS on the      
antimicrobial treatment in selected BSIs when introduced into a routine clinical 
setting. (Study I) 
 
2. To evaluate the blood culture positivity in patients with cSSSI: the rate of 
blood culture positivity; factors associated with clinicians ordering blood 
cultures; factors associated with blood culture positivity and the benefit of 
information obtained from positive blood cultures. (Study II) 
 
3. To evaluate the impact of pre-operative antimicrobial treatment duration on 
the yield of valve cultures and valve PCR from resected endocardial material in 
patients operated for IE and to assess the diagnostic utility of the PCR method 
in this setting. (Study III) 
 
4. To describe the epidemiology, spectrum of causative agents and the outcome 
of infective endocarditis in a population-based study in the Capital Region of 
Finland 2013-2017 and also to compare clinical entities of IE according to the 





4 MATERIALS AND METHODS
4.1 STUDY I: IMPACT OF SI-MALDI-TOF ON ANTIBIOTIC
TREATMENT OF BLOODSTREAM INFECTIONS
4.1.1 STUDY DESIGN AND PATIENT POPULATION
 
All adult patients with blood cultures positive with Pseudomonas aeruginosa, 
Enterococcus spp. and AmpC-producing Enterobacteriaceae (Enterobacter 
spp., Serratia spp., Morganella morganiae) who were treated in Helsinki 
University Hospital, Helsinki, between March 2014 and December 2015 were 
included in the study. Only the first BSI episode was included. Exclusion criteria 
were: lack of verified clinical data, patient not receiving appropriate antibiotic 
treatment at all (e.g., due to poor prognosis), bacteremia episode during 
appropriate antibiotic treatment or blood cultures ruled as a contamination. 
HUS is a tertiary hospital serving population about one and a half million in 
the Hospital District of Helsinki and Uusimaa. HUS is the national center for 
solid organ transplantations and is also responsible for the majority of stem cell 
transplantations nationally. The prevalence of multi-drug resistant 
Pseudomonas aeruginosa (65 cases year 2015) and vancomycin resistant 
enterococci (under 20 cases annually) are low from clinical samples. 
Study design was an observational retrospective cohort study. Patients with a 
BSI caused by the abovementioned bacteria were identified, and information on 
si-MALDI-TOF results was retrieved, from the clinical microbiology laboratory 
database at Helsinki University Hospital Laboratory (HUSLAB). Demographic 
and clinical data were collected from the electronic medical records.  
4.1.2 STUDY GROUPS AND IDENTIFICATION OF BACTERIA IN HUSLAB
 
Blood cultures were incubated in blood culture bottles in Bact/Alert® 
(BioMérieux, France) instrument for a total of 5-6 days or until reported as 
positive.  
 
Study groups and the si-MALDI-TOF method
The si-MALDI-TOF identification was done from all blood culture bottles, which 
flagged positive between 8 p.m. and 11 a.m. If this analysis yielded a result, the 
bacteremic episode was assigned to si-MALDI-TOF group. If blood culture 
bottle flagged positive between 11 a.m. and 8 p.m., the si-MALDI-TOF was not 
done and hence the bacteremic episode was assigned to control group.  
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For the si-MALDI-TOF analysis, 50-100 microliters of blood culture content 
was applied on chocolate agar plates. These plates were incubated for 3-4 hours 
at +35 C in CO2 atmosphere. After incubation, a sample for the MALDI-TOF 
analysis was obtained by streaking the application area on the chocolate agar. 
One spot was inoculated for each sample. The analysis (Vitek MS; bioMérioux) 
was performed even if no growth was visible. The si-MALDI-TOF results were 
reported between 11 a.m. and 2 p.m. the same day. 
Simultaneously with the si-MALDI-TOF analysis another sample from blood 
culture bottle was Gram stained and subcultured on agar plates for 
susceptibility testing and confirmatory identification testing. In addition, a 
sample from a positive blood culture bottle was used for conventional bacterial 
identification; in-house identification set containing 10 biochemical tests along 
with chromogenic plates. Also, conventional MALDI-TOF was performed in 
cases giving unreliable identification in conventional biochemical methods, 
usually the next day. 
Identification by si-MALDI-TOF resulted in initial identification roughly 22-
24 hours earlier compared to identification done by conventional MALDI-TOF 
and biochemical identification methods. 
4.1.3 STUDY DEFINITIONS
 
Polymicrobial bacteremia was defined as the isolation of more than one 
bacterial species during the same bacteremia episode, except in case of a 
contamination. Index bacteria refer to one of the bacteria that are included in 
the study. If a patient had a polymicrobial bacteremia caused by two of the index 
bacteria, these were analysed as separate episodes.  
Appropriate antibiotic therapy was defined as follows: an antibiotic regimen 
to which the index bacteria was susceptible in vitro, considered standard 
treatment according to HUS antimicrobial treatment guide (Martelius et al. 
2016) and, with the exception of fluoroquinolones, delivered intravenously. 
Appropriateness of antibiotic therapy in polymicrobial infections was assessed 
from the perspective of the index bacteria. Time to appropriate antibiotic 
therapy was calculated from the first positive blood culture draw to the delivery 




4.2 STUDY II: FACTORS ASSOCIATED WITH BLOOD 
CULTURE POSITIVITY IN PATIENTS WITH 
COMPLICATED SKIN AND SKIN STRUCTURE
INFECTION
4.2.1 STUDY DESIGN AND PATIENT POPULATION
 
All adult patients residing in Helsinki, Finland and Gothenburg, Sweden and 
who were hospitalized for cSSSI during the study period 2008-2011 were 
included in the study (Jääskeläinen et al. 2016). The study hospitals were HUS 
and Helsinki City Hospital in Finland and Sahlgrenska University Hospital in 
Gothenburg, Sweden. Patients were identified using ICD-10 codes suitable for 
SSSI and those who met the inclusion criteria were included in the study. In 
short, inclusion criteria were: (1) adult patient with hospitalization, (2) SSSI 
affected deeper soft tissue (e.g., cellulitis or fasciitis) or needed surgery, (3) SSSI 
in lower extremity in a patient with diabetes or peripheral vascular disease and 
(4) patient with a major abscess or an infected ulcer. Patients needed also to 
have local signs of cSSSI present plus one systemic sign of infection.  
The study was an observational retrospective population-based cohort study. 
Data on demographics, clinical variables, laboratory and microbiological results 
were collected from medical records.  
4.2.2 STUDY DEFINITIONS
 
Cellulitis/fasciitis was defined as SSSI without an abscess, diabetic foot or an 
infected ulcer. Streamlining was defined as a change of antibiotic therapy to 
pathogen specific one. Clinical stability was defined as improvement of systemic 
and local signs of infection. Treatment failure was defined as need for 
unplanned surgery due to infection, no improvement in clinical situation after 
five days of treatment or judgement of treatment failure by the treating 
physicians. Coagulase-negative staphylococci and other normal skin flora 
commensals were generally considered as contaminants and infectious disease 
specialist assessed each case. 
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4.3 STUDY III: IMPACT OF PRE-OPERATIVE ANTIBIOTIC 
TREATMENT ON MICROBIAL FINDINGS FROM 
RESECTED ENDOCARDIAL MATERIAL
4.3.1 PATIENTS AND STUDY DESIGN
 
Inclusion criteria of the study were: (1) valve surgery due to infective 
endocarditis between 2011-2016 in HUS, (2) age ≥ 18 years, (3) a sample for 
PCR and valve cultures were obtained during surgery and (4) IE was post-
operatively classified as definite or possible according to modified Duke criteria 
(Li et al. 2000). The study was a retrospective single-centre study. Patients were 
recognized using ICD-10 codes for infective endocarditis (i.e., I33, I38 and I39) 
from operating room´s database. Data on demographics, clinical features, 
laboratory results and microbiology were collected from electronic patient 
records. 
In all, 115 patients were identified. Twenty-two were excluded because a 
sample for PCR was not obtained, two were excluded due to missing data and 
two were excluded because IE was classified as “rejected” according to modified 
Duke criteria. In addition, yeast was a causative agent in two patients and they 
were excluded because the broad-range PCR does not recognise yeast and thus 
these were out of the scope of the study.  
HUS is responsible for cardiac surgery in the Hospital District of Helsinki 
and Uusimaa and two smaller hospital districts in Southern Finland. Also, 
patients from the entire country are referred to HUS for cardiac surgery in 
special circumstances (e.g., congenital heart diseases). 
Since 2010, surgeons have been advised to routinely include a sample for 
PCR analysis along with a sample for bacterial culture from resected endocardial 
material, vegetation or pus. Surgeons themselves decided the best location for 
sample collection during operation. Hence, this study evaluates the value of PCR 
analysis implemented in routine clinical setting. 
4.3.2 MICROBIOLOGICAL PROCEDURES
 
Blood cultures were processed as described in section 4.1.2. Samples obtained 
during surgery were sent straight to microbiology laboratory (i.e., HUSLAB) for 
analysis. If necessary, samples were kept in storage for maximum of two days in 
+4 °C before analysis. The clinical samples were cultured by routine diagnostics 
at HUSLAB. Samples were cultivated on chocolate agar and fastidious anaerobe 
agar and incubated at 37 °C until growth was detected or for 7 days in 5% CO2 or 
under anaerobic conditions. Additionally, samples were inoculated into 
thioglycollate broth and cultivated ad 37 °C. 
For 16S rRNA analysis (i.e., PCR analysis), the clinical samples were 
homogenized using a Precellys bead-beater (Bertin Instruments). During the 
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study period two different DNA extraction instruments were used: SelectNAplus 
(Molzym) or Easymag (Biomérieux). Each method has been validated and no 
difference on positivity rate has been observed. Detailed description is provided 
in the original article, supplement Table 1. The ribosomal 16S DNA was 
amplified using primers Forward CLSI and Reverse Bosshard (Edwards et al. 
2012). Also, used polymerases, PCR instruments and thermal cycling conditions 
are listed in supplement Table 1 of the original article. PCR-amplified fragments 
were separated using gel electrophoresis and visualized under ultraviolet light. 
Amplified fragments were then purified and sequencing was done with BigDye 
Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) using forward 
Bosshard primer (Edwards et al. 2012) and an ABI Prism 3100 genetic analyser 
(Thermo Fisher Scientific). After these steps, analysis was performed using 
Basic Local Alignment Search Tool (BLAST; National Center for Biotechnology 
Information, Bethesda, MD, USA). Each sample was tested with an inhibition 
control (amplification of lambda DNA or Oryza sativa gene) and with each run 
a nontemplate control was tested. 
4.3.3 STUDY DEFINITIONS
 
Antibiotic treatment was defined effective if causative agent of IE was 
susceptible to it in vitro or it was according to the ESC guideline (Habib et al. 
2015). It also had to be delivered intravenously. Duration of effective antibiotic 
treatment was counted from the delivery of first dose of intravenous antibiotic 
to the day of operation. 
The PCR result was considered to have a diagnostic impact if it solely 
provided the etiology of IE, if it confirmed positive serology results or if it 
resolved a discrepancy between blood and valve culture results. 
In order to study the impact of the duration of the pre-operative antibiotic 
treatment on the yield of the PCR method two approaches were used. First, the 
median duration of antibiotic treatment of those PCR positive was compared to 
those PCR negative. Second, study population was stratified according to the 
length of antibiotic treatment to five categories (Table 6) to demonstrate and to 
allow comparison between proportions of PCR/valve culture positive patients to   
PCR/valve culture negative patients. In the final analysis, we chose to compare a 
group of patients who received pre-operative antibiotic treatment less than 2 
weeks (n=46) to those who received it 2 weeks or longer (n=34). In order to 
control for possible confounding, independent variables associated with PCR-
positivity in univariate analysis (P<0.2) or with clinical significance were 





Materials and methods 
50 








The design was an observational retrospective study. All adult patients residing 
in the Helsinki University Hospital Area and diagnosed with IE during 2013-
2017 were included in the study cohort. The study hospitals included HUS and 
two Helsinki City Hospitals. The catchment areas of these hospitals form the 
Helsinki University Hospital Area and have the only emergency departments in 
the area. These hospitals are responsible for the treatment of severe infections, 
such as IE. Thus, virtually all patients with IE are being treated in the study 
hospitals. This enables the population-based approach. 
Patients were recognised using ICD-10 codes for IE, i.e., I33, I38 and 139. An 
infectious disease specialist (M.H.) collected all data from the electronic patient 
records. Patients meeting the criteria for possible or definite IE according to the 
modified Duke criteria (Li et al. 2000) were included. Those meeting the 
modified Duke rejected criteria and those residing outside the study area were 
excluded. 
 
Duration of pre-operative 







One day or less 11 10 (91%) 4 (36%) 
2-13 days 35 32 (91%) 15 (43%) 
14-28 days 17 10 (59%) 0 
More than 28 days1 17 8 (47%) 0 
7 days or less, but previous 
longer course2 
7 4 (57%) 0 
1 One patient in this group had a pre-operative IV antibiotic treatment for more than 28 days, but the exact 
duration could not be verified from medical records and thus this one case is left out of the time analysis comparing 
median durations 
2 These patients received for a less than a week IV antibiotics before surgery, but had had a longer continuous 
course of antibiotic treatment before this (targeting other foci in most cases). Thus, this group is left out of all time 






The member municipalities of Helsinki University Hospital Area are Espoo, 
Helsinki, Kauniainen, Kerava, Kirkkonummi and Vantaa. Adult patients who 
resided in these municipalities during the study period were included. A total of 
0.993 million adult patients (approximately one-fifth of Finnish adult 
population) resided in this area 2017. The population is mainly urban. The 
prevalence of methicillin-resistant Staphylococcus aureus (MRSA) was low 
during the study period in study region: 5% of all S. aureus bacteremias in year 
2017 (Haiko et al. 2018). In year 2012, in the study area there were an estimated 
5,600-10,300 problem drug users (i.e., abusers of amphetamine and/or 




IE episodes were categorized according to the mode of acquisition into mutually 
exclusive groups: community-acquired IE (CAIE), health care-associated IE 
(HAIE) and intravenous drug use-related IE (IDUIE).  
HAIE was defined as follows: 1) onset of IE more than 48 hours after 
admission or within six months after discharge from hospital stay of ≥ 2 days, 2) 
IE developed within six months after a significant procedure performed during 
hospitalization or ambulatory setting, (3) IE developed within one month after 
extensive out-of-hospital contact with health care (e.g., dialysis, wound care, 
intravenous treatment) or (4) residence in a nursing home or similar facility 
(Friedman et al. 2002, Ben-Ami et al. 2004, Fernandez-Hidalgo et al. 2008). 
PVE was defined as “early onset” if it occurred within 12 months after surgery 
and was defined as HAIE.  
Patients with a history of intravenous drug use within one month before 
diagnosis of IE were classified as IDUIE even if health care association was 
present.  
Patients not meeting the definition of HAIE or IDUIE were classified as 
CAIE. Dental procedure was not considered a criterion for HAIE (Fernandez-
Hidalgo et al. 2008). 
IE was defined as definite or possible according to the modified Duke criteria 
(Li et al. 2000). An episode of IE occurring after the initial IE episode was 
considered a relapse if it occurred within six months after the end of the 
antimicrobial therapy of the initial IE episode and the causative agent was 
similar (Chu et al. 2005), in any other case it was considered a new episode (i.e., 
re-infection) and was included in the study as a separate episode.  
Valve abnormalities (e.g., degenerative valve lesions), prosthetic valve and 
cardiac devices, congenital heart disease and non-mild hypertrophic 
cardiomyopathy were considered as predisposing heart condition to IE. Left-
sided IE was defined as IE affecting only aortic and/or mitral valves, and right-
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sided IE only tricuspid and/or pulmonary valves. Location of IE was determined 
by echocardiogram, other imaging studies, surgery or clinically. Septic emboli or 
deep focus was defined as a focus of infection (other than cardiac) verified by 
imaging studies or clinically and related to IE. Operative treatment for IE was 
considered in a case where a patient had valve operation with IE indication 
during ongoing antimicrobial treatment. Time to operation was calculated from 
the first day on effective antimicrobial treatment. Effective antimicrobial 
treatment was defined as a regimen to which the causative agent of IE was 
susceptible to in vitro or was in accordance to recommendation of ESC (Habib 
et al. 2015) and delivered intravenously.  
 
4.5 STATISTICAL METHODS (STUDIES I-IV)
Descriptive statistics were applied in summarizing the variables. Categorical 
variables were summarized using counts and percentages. Continuous variables 
were summarized using means with standard deviation or medians with min 
and max values and interquartile range (IQR) or range, if sample was small. 
For comparison of two groups, categorical variables were compared using 
either chi-square test or Fisher´s exact test, when appropriate, and continuous 
variables were compared using Mann Whitney U –test. Odds ratio (OR) was 
calculated with 95% confidence interval (CI). 
P-value less than 0.05 was considered statistically significant. All statistical 
analyses were performed using SPSS versions 22.0 – 25.0 (IBM Corp., Armonk, 
N.Y., USA). 
 
Study I. Kaplan-Meier method and Log-Rank test were used to analyze survival 
type data.  
 
Study II. Bivariate logistic regression analysis (enter method) was used to 
determine the independent factors associated with blood culture sampling and 
blood culture positivity. First, univariate analysis was performed. Variables with 
P-value less than 0.15, those with clinical significance and those not 
multicollinear were then entered into the model.  
 
Study III. To control for possible confounding, bivariate logistic regression 
analysis (enter method) was used in analysis of the length of pre-operative 
antibiotic treatment on PCR positivity. After univariate analysis, variables with 
P-value less than 0.2 and those with clinical significance were included in the 
model. 
 
Study IV. Percentages were counted using total number of IE episodes as the 
denominator, unless otherwise specified. Poisson regression was used to 
calculate the 95% CIs for incidence rates and to examine the trends in incidence 
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rates. Comparisons of CAIE to HAIE and CAIE to IDUE were done by 
multinomial logistic regression.  
4.6 COMPLIANCE WITH ETHICAL STANDARDS
The research board at the Inflammation Center, HUS approved the study 
protocols for studies I-IV. Additionally, for study II, the ethical committee of 
Sahlgrenska University Hospital, Sweden also approved the study protocol, 
along with local conventional manner. For study IV, additional approve from 
Helsinki City was obtained. Given the retrospective nature of all studies, no 
ethical committee approval from HUS was needed. 
Throughout this thesis work, the research was conducted in strict compliance 







5.1 STUDY I: IMPACT OF SI-MALDI-TOF ON ANTIBIOTIC 
TREATMENT OF BLOODSTREAM INFECTIONS
5.1.1 PATIENTS, STUDY GROUPS, FOCUS/SOURCE OF INFECTION AND 
OUTCOME OF BSIS
 
A total of 164 episodes of bacteremia were identified. After excluding 40 
episodes, 124 bacteremia episodes originating from 120 patients were included. 
One patient had two separate bacteremias of different index bacteria during the 
study period. Three patients had a polymicrobial bacteremia caused by two of 
the index bacteria. Fifteen polymicrobial bacteremia episodes including one of 
the index bacteria were included. 
A total of 124 bacteremia episodes were divided into two groups: i) si-
MALDI-TOF group (n=69) in which si-MALDI-TOF was used for bacterial 
identification with a positive result and ii) control group (n=54) in which 
identification was done by means of conventional methods. 
There were no significant differences between the study groups in baseline 
characteristics, focus of infection or outcomes (Table 7). 
The acquisition site of blood cultures were as follows: emergency room 
33.9% (n=42), ICU 12.9% (n=16), internal medicine ward (incl., neurology and 
pulmonology) 4.8% (n=6), hematology ward 13.7% (n=17), surgical ward 25.8% 
(n=32), gynecology ward 3.2% (n=4) and oncology ward 5.6% (n=7) of cases. 
5.1.2 MICROBIOLOGY AND ANTIBIOTIC TREATMENT
 
Pseudomonas aeruginosa caused 16.9% (n=21), Enterococcus spp. 50% (n=62) 
and AmpC-producing Enterobacteriaceae 33.1% (n=41) of included bacteremia 
episodes. Detailed description of the causative bacteria is presented in Table 8. 
Of monobacteremias (n=103), si-MALDI-TOF was used in 65 and yielded a 
result in 62. It did not recognise the bacteria in one E. faecalis and in two E. 
cloacae bacteremias. Of polymicrobial bacteremias, si-MALDI-TOF was used in 
14 and yielded a result in 7 (for the index bacteria). 
 
Early empiric antibiotic therapy 
Within 12 hours after the positive blood culture draw in 75.8% (n=94) of 
bacteremia episodes antibiotic treatment was either started or changed, in 
19.4% (n=24) no change was made to the ongoing antibiotic treatment and in 
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4.8% (n=6) patient did not receive any antibiotic treatment. This early empiric 
antibiotic treatment was appropriate only in 22.6% (n=28) cases. 
 
 
Table 7. Patient characteristics, infection focus or source and clinical outcome of the study 
population (n=124) and according to study groups.
 








 Age, years  (mean; SD) 61.3; 15.2 62.7; 15.6 59.6; 14.7 0.257 
 Gender, male; n (%) 74 (59.7) 42 (60.9) 32 (58.2) 0.762 
 Chronic heart disease 14 (11.3) 9 (13.0) 5 (9.1) 0.490 
 Chronic kidney disease 22 (17.7) 11 (15.9) 11 (20.0) 0.557 
 Dialysis 4 (3.2) 2 (2.9) 2 (3.6) >0.99 
 Liver cirrhosis 5 (4.0) 4 (5.8) 1 (1.8) 0.381 
 Chronic lung disease 18 (14.5) 11 (15.9) 7 (12.7) 0.614 
 Diabetes 26 (21.0) 14 (20.3) 12 (21.8) 0.835 
 Blood malignancy1 14 (11.3) 10 (14.5) 4 (7.3) 0.207 
 Acute leukemia 15 (12.1) 9 (13.0) 6 (10.9) 0.717 
 Stem cell transplant 5 (4.0) 2 (2.9) 3 (5.5) 0.654 
 Solid organ malignancy 32 (25.8) 16 (23.2) 16 (29.1) 0.456 
 Solid organ transplant 18 (14.5) 10 (14.5) 8 (14.5) 0.993 
 Immunosuppressive treatment2 70 (56.5) 44 (63.8) 26 (47.3) 0.066 
 Neutropenia3 21 (16.9) 14 (20.3) 7 (12.7) 0.265 
Infection focus or source 
 Pulmonary 5 (4.0) 2 (2.9) 3 (5.5) 0.654 
 Urinary tract 21 (16.9) 13 (18.8) 8 (14.5) 0.526 
 Skin / musculoskeletal 7 (5.6) 5 (7.2) 2 (3.6) 0.461 
 Abdominal cavity 55 (44.4) 28 (40.6) 27 (49.1) 0.343 
 Central nervous system 1 (0.8) 1 (1.4) 0 >0.99 
 Heart 2 (1.6) 1 (1.4) 1 (1.8) >0.99 
 Indwelling catheter 5 (4.0) 1 (1.4) 4 (7.3) 0.170 
 Unknown 28 (22.6) 18 (26.1) 10 (18.2) 0.296 
Clinical outcome4 
        7-day mortality                                    3 (2.4) 
        30-day mortality                                 16 (12.9) 
 
1 other than acute leukemia 
2 anti-rejection medication, cancer chemotherapy, prednisolone more than 10 mg/day and anti-rheumatic medications including 
biological medications 
3 absolute neutrophil cell count less than 0.5 x 105 neutrophils/ml 






In a subgroup of BSIs caused by Enterococcus spp. (n=62) early empiric 
antibiotic therapy was inappropriate in 83.9% (n=52) cases. An effective 
coverage was reached by widening the regimen with vancomycin or linezolid in 
two-thirds of the cases and alternatively with a beta-lactam effective against 
enterococci in one-third of the cases. 
 
 
















5.1.3 IMPACT OF SI-MALDI-TOF ANALYSIS ON ANTIBIOTIC TREATMENT
 
In 72.6% (n=90) of all bacteremia episodes patients received appropriate 
antibiotic treatment within 48 hours from the first positive blood culture draw. 
This percentage was 78.3% (n=54/69) in si-MALDI-TOF group and 65.5% 
(n=36/55) in control group (P=0.112). In a Kaplan-Meier analysis similar trend 
was observed (log rank 0.139; Study I, Figure 1). 
Median time from blood culture draw to receipt of appropriate antibiotic 
treatment was 33.5 hours (IQR, 19.3-49.5) in whole study group and in si-
MALDI-TOF group median time was 31.9 hours (IQR, 14.9-46.8) and in control 
group 39.7 hours (IQR, 21.2-61.4); P=0.230. 
 
Pseudomonas aeruginosa group (n=21)
In si-MALDI-TOF group 78.6% (n=11/14) received appropriate antibiotic 
treatment within 48 hours from the blood culture draw compared to 71.4% 
(n=5/7) in control group; P>0.99. 
 







Pseudomonas aeruginosa 21 14 7 0.265 
Enterococcus spp.1 62 33 29 0.588 
AmpC-producing   
Enterobacteriaceae2 
41 22 19 0.754 
1 E. faecalis n=22; E. faecium n=37; E. casseliflavum n=3; with equal distribution in the 2 
study groups  
2 Enterobacter cloacae n=21; E. aerogenes n=2; Serratia liquefaciens n=1; S. marcescens 
n=13; Morganella morganii n=4; with equal distribution in the 2 study groups 
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Enterococcus spp. group (n=62)
In Si-MALDI-TOF group 87.9% (n=29/33) received appropriate antibiotic 
treatment within 48 hours from the blood culture draw compared to 65.5% 
(n=19/29) in control group; P=0.036. 
Amp-C-producing Enterobacteriaceae group (n=41)
In si-MALDI-TOF group 63.6% (n=14/22) received appropriate antibiotic 
treatment within 48 hours from the blood culture draw compared to 63.2% 
(n=12/19) in control group; P=0.975. 
Subgroup of patients with immunosuppressive medication (n=70)
In si-MALDI-TOF group 86.4% (n=38/44) received appropriate antibiotic 
treatment within 48 hours from the blood culture draw compared to 57.7% 
(n=15/26) in control group (P=0.007; Study I, Figure 2). 
 
5.2 STUY II: FACTORS ASSOCIATED WITH BLOOD 
CULTURE POSITIVITY IN PATIENTS WITH 
COMPLICATED SKIN AND SKIN STRUCTURE 
INFECTION
5.2.1 STUDY COHORT, BLOOD CULTURE POSITIVITY AND RESULTS
 
In all, 460 patients with cSSSI were included in the study. Demographics, co-
morbidities and clinical features are summarized in Table 1, Study II.  
Blood cultures were obtained from 258 patients (51.6%) and they were 
positive in 61 patients (23.6%). The proportion of blood culture positivity was 
nearly equal in the two centres: 23% in Helsinki and 25% in Gothenburg. 
Streptococcus pyogenes (n=19, 31%) and Staphylococcus aureus (n=19, 
31%) were the two most common findings followed by non-A beta-hemolytic 
streptococci (n=12, 20%). Streptococcus pneumoniae was found in one patient. 
Notably, in only one case gram-negative bacteria was isolated. Five cases (8%) 
were polymicrobial and four (7%) were unknown. 
5.2.2 FACTORS ASSOCIATED WITH BLOOD CULTURE SAMPLING
 
To determine the factors associated with blood culture draw we compared 
patients from whom blood cultures were drawn (n=258) to those from whom 
they were not drawn (n=202; Table 1, Study II). We used both univariate and 
multivariate analysis, which differs from the analysis done in the primary 




In multivariate analysis, diabetes (OR 1.9, CI 1.2-2.9), duration of symptoms 
shorter than 2 days (3.0, 1.8-5.2) and CRP > 150 mg/L at the time of diagnosis 
of cSSSI (1.8, 1.2-2.8) were associated with more frequent blood culture 
sampling. Whereas peripheral vascular disease (0.5, 0.3-0.8) and post-surgical 
wound infection (0.4, 0.2-0.8) were associated with less frequent blood culture 
sampling. In addition, median CRP measured at the time of the diagnosis was 
significantly higher in patients with blood culturing compared to those without 
blood cultures (181 mg/L vs 130 mg/L, P=0.003). 
5.2.3 FACTORS ASSOCIATED WITH BLOOD CULTURE POSITIVITY
 
In order to determine the factors associated with blood culture positivity we 
compared patients with positive blood cultures (n=61) to those from whom 
blood culture sample was taken but it was negative (n=197). This approach 
differs from the original publication of this material where blood culture 
positive patients were compared to the rest of the study group (Jääskeläinen et 
al. 2016). 
In multivariate analysis only alcohol abuse was significantly associated with 
blood culture positivity (OR 5.5, CI 2.3-13.2). Full results of univariate and 
multivariate analysis are shown in Table 2, Study II. In addition, neither the 
CRP measured at the time of the diagnosis of cSSSI nor the highest CRP 
measured during the hospitalization was associated with bacteremia (Table 2, 
Study II). Blood culture positivity rates among the patients from whom blood 
culture was obtained categorized according to CRP count are illustrated in 
Figure 2. No statistical difference between the groups in percentages of 







Figure 2 Blood culture positivity and negativity by categorized CRP levels.
Clinical endpoints in blood culture positivity
Patients with blood cultures positive had antibiotic treatment streamlined more 
often compared to blood culture negative patients (23.3% vs 6.3%, OR 4.5 [CI 
2.0-10.5], P<0.001). In addition, patients with bacteremia reached clinical 
stability less likely in three days compared to patients without bacteremia (30% 
vs 52%, OR 0.4 [CI 0.2-0.8], P=0.006). Bacteremia was also associated with 
increased ICU admissions and longer hospital stay. However, no differences 
were observed in rate of surgical interventions after the diagnosis of cSSSI, 
length of antibiotic therapy or 30-day mortality. See Table 3, Study II for 
specific details. 
 
5.3 STUDY III: IMPACT OF PRE-OPERATIVE ANTIBIOTIC 
TREATMENT ON MICROBIAL FINDINGS FROM 
ENDOCARDIAL SPECIMENS
5.3.1 PATIENT DEMOGRAPHICS, CLINICAL FEATURES AND OUTCOME
 
In all, 87 patients were included in the study cohort. Eighty-five were classified 
as having definite IE and two patients had possible IE according to the modified 
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Bacteremia + Bacteremia - Blood culture not taken
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(81.6%) of them were male. Known predisposing heart disease was observed in 
24 (27.6%) patients and seven (8%) had a history of previous IE. Co-morbidities 
were found as follows: chronic kidney disease in four (of these three were on 
hemodialysis and one on peritoneal dialysis), liver cirrhosis in four and diabetes 
(requiring medication) in 17 (19.5%). Eleven (12.6%) patients had a history of 
alcohol abuse and 14 (16.1%) had intravenous substance abuse. 
Most of the operated patients had NVE (n=76, 87.4%). A cardiac device was 
involved in two cases. A total of 105 valves were operated, 50 of these were 
aortic, 47 mitral, seven tricuspid and one pulmonary valve.  
Septic emboli or other deep focus complicated the course in approximately 
half of the cases (n=48, 55.2%). Relapse of IE occurred in four cases within 12 
months of the operation. 30-day all-cause mortality was observed in 8% (n=7) 
and 365-day all-cause mortality in 17.2% (n=15) of cases. 
5.3.2 MICROBIOLOGY OF BLOOD CULTURES, VALVE CULTURES AND 
PCR
 
A total of 89 samples for PCR were obtained from 87 patients. From two 
patients two samples were obtained, and one in the rest of the cases. In case of 
80 patients a sample for PCR was obtained from endocardial material or 
vegetation, and in seven cases from pus (e.g., from paravalvular abscess). A total 
of 101 valve cultures were obtained, two samples from 14 patients and one 
sample from 73 patients. All PCR and valve culture results are hereby presented 
as per patient. 
The full results of the blood and valve cultures and PCR are presented in 
Table 4, Study III. 
 
Blood cultures
Blood cultures were positive in 74 (85%) of cases. Staphylococcus aureus 
(n=25) was the most common finding followed by viridans group streptococci 
(n=20) and Enterococcus faecalis (n=9) and coagulase-negative staphylococci 
(n=8). Of the coagulase-negative staphylococci four were Staphylococcus 
epidermidis, three Staphylococcus lugdunensis and one was not named to 
species level. In 13 (15%) of cases blood cultures were negative, and etiology was 
determined in 10 of these cases by PCR from resected valve.  
Valve cultures
Valve cultures were positive in 19 (22%) cases (Table 4, Study III). In two cases 
the valve and blood culture results differed. In one case, Streptococcus mitis was 
cultured from valve sample and also found by PCR, but blood cultures were 
negative. In the other case, Staphylococcus epidermidis were found in valve 
cultures, but Streptococcus salivarius was found in blood cultures and in valve 
PCR. In this case the valve culture result was regarded as a contaminant. In 
addition to this, in only one other case culture result was considered as a 
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contaminant. In this other case Cutibacterium acnes grew on culture (taken 
from pus from a mediastinal site) and blood cultures grew Enterococcus 
faecalis. Infectious disease specialists evaluated both these cases.  
 
16S rRNA PCR and sequencing
In total of 64 (74%) of cases PCR was positive (Table 4, Study III). Of these cases 
54 were also blood culture positive with matching results and in 10 cases blood 
cultures were negative. In one case valve culture was positive but PCR remained 
negative. No false-positive results were found. In one case a mixed sequence was 
suspected (two viridans group streptococci). In the two cases where two samples 
for PCR were taken they showed similar results (both positive in both cases). 
5.3.3 DIAGNOSTIC IMPACT OF THE PCR RESULT
 
PCR was considered to contribute markedly to the etiological diagnosis in 12 
patients (Table 5, Study III). In five cases PCR solely provided the etiology: 
Bartonella quintana in two cases and Coxiella burnetii, Streptococcus gordonii 
and Streptococcus pneumoniae each in one. In the cases of the latter two, blood 
cultures were negative due to prior antimicrobial treatment.  
5.3.4 IMPACT OF THE DURATION OF THE PRE-OPERATIVE ANTIBIOTIC 
TREATMENT ON THE YIELD OF THE VALVE CULTURE AND PCR
 
All patients with positive valve cultures (n=19) received pre-operative antibiotic 
treatment less than two weeks. 
The median duration of pre-operative effective antibiotic therapy in PCR-
positive patients (n=60) was significantly shorter compared to PCR-negative 
patients (n=19 [8.5 days vs 24 days, P=0.001]). In addition, the proportion of 
PCR-positive patients in those who received less than two weeks of antibiotic 
treatment pre-operatively was significantly higher compared to the proportion 
of PCR-positive patients in those who received it for two weeks or longer (91% vs 
53%, P<0.001), see also Table 6. Moreover, in multivariate logistic regression 
analysis only duration of pre-operative antibiotic treatment less than 2 weeks 
remained significantly associated with PCR-positivity (OR 7.2, 95% CI 2.0-26.0, 






5.3.5 IE CAUSED BY BARTONELLA QUINTANA, COXIELLA BURNETII 
AND TROPHERYMA WHIPPLEI (CASES FROM STUDIES III AND IV)
 
A total of nine patients had IE caused by Bartonella quintana. Median age was 
55 years (range 24-86) and eight patients were male. Aortic valve alone was 
affected in five, both aortic and mitral valves in one and mitral valve alone in 
three cases. Two patients had septic emboli and three patients had IE-associated 
glomerulonephritis. Five patients had a history of alcohol abuse and/or 
homelessness, but four did not. Six patients were surgically treated and all had 
valve PCR positive. One conservatively treated patient had PCR positive from 
pseudoaneurysm of superior mesenteric artery. Serology was tested for six 
patients and was positive in every case. One patient died during hospitalization, 
others survived. Interestingly, two patients had PVE (bioprosthesis) and these 
two cases were also blood culture positive (in extended culturing). In both cases 
microbiology laboratory was informed beforehand of the suspicion of Bartonella 
quintana IE. 
Two patients had IE caused by Tropheryma Whipplei. Patients were: 65 
year-old man and 48 year-old woman, and both were otherwise healthy but had 
a long history of arthralgia before diagnosis. Diagnosis was established by valve 
PCR in both cases. 
Two patients had IE caused by Coxiella burnetii. Both were male, aged 66 
years and 71 years. Sixty-six year old man had a predisposing heart condition 
and a travel history to Canary Islands, Spain. IE diagnosis was established by 
valve PCR and serology. The other patient had a bioprosthesis and travel history 
to endemic area. In this case diagnosis was based on serology. 




In all, 313 episodes of IE occurring in 291 patients were included in the study 
cohort. Median age was 55 years (range, 19-98; interquartile range [IQR], 36-
71). A male-to-female ratio was approximately 2:1, as 68.7% (n=215) of IE 
episodes occurred in men and 31.3% (n=98) in women. Of IE episodes, 78.9% 
(n=247) were classified as definite and 21.1% (n=66) as possible according to the 
modified Duke criteria (Li et al. 2000). 
Of the whole study cohort, 40.9% (n=128) had known pre-existing cardiac 
risk factor, 14.4% (n=45) had diabetes, 2.9% (n=9) liver cirrhosis, 10.9% (n=34) 
chronic kidney disease, 7.0% (n=22) were on dialysis and 5.4% (n=17) had 
immunosuppressive treatment. A history of previous IE was documented in 





Community-acquired IE (CAIE) accounted for 38.0% (n=119) of IE episodes, 
health care-associated IE (HAIE) 31.0% (n=97) and intravenous drug use-
related IE (IDUIE) 31.0% (n=97). 
Median age in CAIE group was 64 years (IQR, 52-75), in HAIE group 69 
years (IQR, 58-77) and in IDUIE group 35 years (IQR, 29-38). Patients in 
IDUIE group were significantly younger compared to CAIE group (P<0.001) 
and to HAIE group (P<0.001) and no statistical difference in age between CAIE 
and HAIE groups was observed (P=0.365). Figure 3 shows the number of IE 
episodes by age and mode of acquisition.  
The median age in patients without a history of IDU was 66 years (IQR 53-
75.8) and women were older than men (median 72 years vs median 65 years, 
respectively, P=0.001).  
Comparison of CAIE group to HAIE and IDUIE in patient demographics and 
co-morbidities is shown in Table 3, Study IV. Of note, patients with HAIE had 
more underlying comorbidities compared to CAIE. Eventhough in IDUIE group 
male predominance was observed (59.8%), the proportion was significantly 
smaller compared to CAIE (73.1%, P=0.039). 
 





The incidence was found to be 6.48/100,000 person-years (95% CI, 5.80-7.24) 
in adults. No significant change in incidence between the study years was 
observed. Annual incidence rates according to the mode of acquisition were 
2.46/100,000 (95% CI, 2.06-2.95) for CAIE, 2.01/100,000 (95% CI, 1.65-2.45) 
for HAIE and 2.01/100,000 (95% CI, 1.65-2.45) for IDUIE. No significant 
change in these incidence rates during the study period by mode of acquisition 
was observed either: CAIE P=0.903, HAIE P=0.324, IDUIE P=0.650. In Figure 







Figure 4 Number of IE episodes by year of the diagnosis of IE and mode of acquisition.
5.4.2 LOCATION OF IE
 
Transthoracic echocardiography was performed in every episode and 
transesophageal echocardiography in 57.5% (n=180) of cases. Native valve was 
affected in 83.7% (n=262) of cases. Majority of PVEs occurred in biovalves 
(n=39) following mechanical valves (n=7), mitral plasty (n=2) and transcatheter 
aortic valve implant (TAVI; n=3). Composite graft was involved in 1.3% (n=4) 
and pacemaker in 1.6% (n=5) of IE episodes. One-fifth of PVEs were early PVEs 
(n=11/51). 
Aortic valve alone was affected in 40.3% (n=126) of cases, mitral valve alone 
in 31.6% (n=99), both aortic and mitral valves in 3.5% (n=11) and tricuspid valve 
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alone in 20.1% (n=63). Pulmonary valve was affected in four cases, of which in 
two cases alone and in one with mitral valve and in one with tricuspid valve. IE 
was left-sided in 75.4% (n=236) of cases, right-sided in 21.1% (n=66) and both-
sided in 3.5% (n=11). Comparison of location of IE according to mode of 
acquisition is presented in Table 3, Study IV. Of note, patients with IDUIE had 
right-sided and both-sided infection more commonly than patients in CAIE 
group. Prosthetic valve was affected in one-third of HAIE cases, and over three 
times more frequently than in CAIE. 
5.4.3 ETIOLOGY 
 
The etiology of IE was determined in 91.4% (n=286) of episodes. Blood cultures 
were positive in 87.5% (n=274) of cases. Of the 39 blood culture-negative cases 
etiology was resolved in 30.8% (n=12) by following methods: PCR from resected 
valve (n=4), PCR and culture from resected valve (n=1), PCR from resected 
valve and serological testing (n=2), culture from other site (i.e., deep focus or 
septic embolus; n=3), PCR from thrombotic mass in artery and serology (n=1) 
and serology only (n=1). Etiology remained unknown in 8.6% (n=27) of cases. 
Staphylococcus aureus was the leading causative agent. It caused 36.1% 
(n=113) of IE cases. Second was viridans group streptococci 21.4% (n=67) and 
third Enterococcus spp. 9.9% (n=31). Detailed microbiology results are 
presented in Table 2, Study IV. Comparison of microbial etiology of IE 
according to the mode of acquisition is presented in Table 3, Study IV. 
Staphylococcus aureus was equally common in CAIE and HAIE. Viridans group 
streptococci were more frequently and Enterococcus spp. less frequently 
responsible for IE in CAIE compared to HAIE. In fact, two-thirds of all 
enterococcal IEs belonged to HAIE group. S. aureus caused 74.2% of IDUIE 
cases. 
In left-sided IE (n=236) S. aureus constituted 22% (n=52), viridans group 
streptococci 27.5% (n=65) and Enterococcus spp. 12.3% (n=29) of cases. 
In patients with left-sided IE, no difference between PVE and NVE were 
observed in cases caused by S. aureus (17.4% vs 23.2%, respectively, P=0.397) 
or viridans group streptococci (21.7% vs 29.1%, P=0.317), but Enterococcus spp. 
were the etiological agent more often in PVE (21.7%) compared to NVE (10.0%, 
P=0.030). 
5.4.4 COMPLICATION OF IE
 
Septic complication was observed in 51.8% (n=162) of IE episodes. Cerebral 
complication (e.g., radiologically verified infarct or haemorrhage) occurred in 
14.4% (n=45) episodes and septic emboli other than cerebral complicated the 
course of IE in 46.3% (n=145) of cases (Table 1, Study IV). Besides cerebral 
complications, septic emboli were detected in lungs in 24.9% (n=78), in visceral 
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organs in 12.8% (n=40), in musculoskeletal sites in 17.6% (n=55) and in other 
sites in 8.0% (n=25) of IE cases. 
In 9.3% (n=29) of IE episodes patients were admitted to intensive care unit 
(ICU) during the hospitalization (post-operative admissions not included). Of 
the patients who were not admitted to ICU (n=284), nearly one-third (n=94) 
needed treatment in intermediate care unit (IMCU) or cardiac care unit (CCU). 
Mechanical or non-invasive ventilation due to heart failure was needed in 14.7% 
(n=46).  
There were no difference in cerebral complication between CAIE and HAIE 
or CAIE and IDUIE, but patients with IDUIE had significantly more septic 
emboli (or deep foci) compared to CAIE group (Table 4, Study IV). 
5.4.5 TREATMENT AND OUTCOME
 
Median duration of effective intravenous antibiotic treatment was 35.5 days 
(IQR, 29-44.8) for the whole study group (data missing in 1 case). In patients 
with NVE median duration was 33 days (IQR, 29-43) and for PVE 43 days (IQR, 
29-49). 
In cases where empirical antimicrobial treatment was started after blood 
culture sampling (n=238), in 79 % (n=188) of cases it was considered effective 
against the causative organism and in 21% (n=50) ineffective. In 27 episodes the 
etiology remained unresolved and thus the effectiveness of empirical antibiotic 
therapy could not be evaluated. In 45 episodes intravenous antimicrobial 
treatment was initiated after preliminary blood culture results and in two 
episodes patients did not receive effective intravenous antibiotic at all. 
In 23% (n=72) of IE episodes valve surgery was performed during ongoing 
antimicrobial treatment. Median time to surgery from the start of effective 
intravenous antimicrobial treatment was 14 days (IQR, 7.3-34.8). In NVE 
operation was performed in 23.3% (n=61/262) cases and median time to 
surgery was 11 days (IQR, 7-32.5) and in PVE operation was performed in 21.6% 
(n=11/51) and median time to surgery was 39 days (IQR, 19-70). No statistical 
difference was observed in surgery rates between NVE and PVE (P=0.790), but 
the median time to operation was significantly longer for patients with PVE 
(P=0.005). Patients with CAIE had surgery more often than IDUIE group (Table 
4, Study IV). 
In-hospital all-cause mortality rate was 17.3% (n=54) and one-year all-cause 
mortality rate was 25.9% (n=81). Of those who survived the IE episode (n=259) 
3.5% (n=9) had a relapse. Comparison between mortality rates according to the 
mode of acquisition is presented in Table 4, Study IV. Of note, HAIE was 
associated with increased both in-hospital and one-year mortality compared to 
CAIE. 
For patients with PVE in-hospital mortality was 25.5% (n=13) and with NVE 
15.6% (n=41; P=0.089). One-year mortality for PVE was 43.1% (n=22) and for 




6.1 STUDY I: IMPACT OF SI-MALDI-TOF ON ANTIBIOTIC
TREATMENT OF BLOODSTREAM INFECTIONS
Considering that empiric antibiotic treatment is seldom modified until more 
microbial or clinical evidence is obtained, which may take up to 48 hours, 
microbiological methods that accelerate the identification of bacteria in positive 
blood cultures are of utmost importance. This is especially emphasized in BSIs 
caused by bacteria with such natural resistance profile that the commonly used 
empirical antibiotic treatments may be ineffective, e.g., the bacteria included in 
our study. Indeed, in the present study we observed that antibiotic treatment 
was appropriate only in 22.6% of bacteremia episodes within 12 hours after the 
blood culture draw.  
In this study si-MALDI-TOF was shown to increase the proportion of 
bacteremia episodes with appropriate antibiotic treatment by 12.8% within 48 
hours from the blood culture draw (78.3% vs 65.5%, P=0.112). This is in line 
with a crossover study including 253 episodes of bacteremia comparing 
traditional identification methods to direct MALDI-TOF in routine clinical 
setting which showed an 11.3% increase in proportion of patients on appropriate 
antibiotic treatment within 24 hours after blood culture positivity (64% vs 75%, 
P=0.01; Vlek et al. 2012).  
Identification by direct MALDI-TOF led to a treatment modification in 13% 
of BSIs in a prospective study including 157 BSIs (Martiny et al. 2013). However, 
this study lacked a control group. A study assessing the benefits of short 
incubation MALDI-TOF in clinical routine found information acquired from it 
leading to a change in empiric antibiotic therapy in one-fifth of patients with 
bacteremia (179 antibiotic orders analysed) and three quarters were evaluated 
rational by the authors (Köck et al. 2017). Contradicting our findings, Jeon and 
colleagues observed that use of MALDI-TOF alone did not significantly reduce 
the time to effective therapy and pointed out the benefit of concomitant ID 
assessment (Jeon et al. 2018). However, they did not use direct or short 
incubation technique, but a subculture of 18-24 hours, which method differs 
from ours. 
The impact of si-MALDI-TOF was shown especially in BSIs caused by 
Enterococcus spp. in which a significantly higher percentage of cases received 
appropriate antibiotic therapy within 48 h after blood culture draw in si-
MALDI-TOF group (87.9%) compared to control group (65.5%, P=0.036). 
In a study including 202 gram-negative bacteremias, impact of enhanced 
MALDI-TOF reporting on empiric antibiotic therapy was maximal in case of 
AmpC-producing Enterobacteriaceae as MALDI-TOF had an impact on empiric 
antibiotic therapy in 35% of bacteremia episodes in whole group, but in case of 
AmpC-producing Enterobacteriaceae (n=27) in 60% (Clerc et al. 2013). In our 
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study we could not confirm this finding, eventhough the number of AmpC-
producing Enterobacteriaceae in our study was higher. Possible explanation is 
that in a study by Clerc and colleagues only patients with ID consultation were 
included whereas in our study it was not mandatory. In a recent study 
conducted in a setting with active ASP and low resistance rates, direct MALDI-
TOF had limited impact on antibiotic treatment in whole study group (n=240), 
but in a subgroup of patients (n=100) with BSI caused by AmpC-producing, 
non-fermenting organisms, S. aureus, Streptococcus and Enterococcus spp. 
active therapy was administered more frequently within 48 hours in MALDI-
TOF group (Osthoff et al. 2017).  
An interesting and important finding in our study was the impact of si-
MALDI-TOF in a subgroup of patients with immunosuppressive medication (n= 
70). In si-MALDI-TOF group in 86.4% (n=38/44) of bacteremic episodes 
patients received appropriate antibiotic treatment within 48 hours after blood 
culture draw whereas the corresponding percentage was 57.7% (15/26) in 
control group (P=0.007). The difference remains significant also when looking 
at only those episodes with inappropriate initial empiric antibiotic therapy 
(n=54, 81.8% vs 46.7%, P=0.008). Also, the proportions of different bacteria in 
study groups were the same. Possible explanation might be that treating 
physicians observe this group of patients more closely and hence the full 
potential of rapid identification is exploited.  
Our study adds to the weight of evidence on the benefits of si-MALDI-TOF 
identification on antibiotic treatment of BSI. However, as a recent review noted, 
further studies are needed, and it emphasized that earlier information should 
also lead to an appropriate clinical response (Dixon et al. 2015). This remark is 
underlined by a study showing that MALDI-TOF method was more powerful 
when combined with ASP intervention than alone (Berganovic et al. 2017).  
The strength of this study is that it provides real-life data on the effect of si-
MALDI-TOF implementation in routine microbial diagnostics in a low 
resistance setting and its effect can be independently evaluated. We chose to 
include only BSIs caused by certain bacteria (i.e., the index bacteria) which are 
often health care-associated and due to their natural resistance profile are often 
non-susceptible to first line empiric antibiotic treatment. This approach enabled 
the high number of the index bacteria in our study compared to others, but may 
overestimate the impact of si-MALDI-TOF. Another strength is diverse patient 
population.  
This study has limitations. It is a single center study and it is retrospective. 
Bacteremia episodes were not randomized into separate groups, so inevitable 
selection bias may exist. Appropriate de-escalation of antibiotic therapy was not 
evaluated. However, the natural resistance profile of the index bacteria itself 
necessitates use of broader-spectrum antibiotics. This study was done in a low 
resistance environment so these results might not be generalizable to a high 
resistance setting. Finally, the study was not large enough to evaluate the si-
MALDI-TOF method´s impact on clinical outcomes, such as mortality or length 
of stay. However, time to appropriate antibiotic therapy is probably better 
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indicator to assess the benefits of molecular rapid detection, as true mortality 
benefits may be difficult to detect (Timbrook et al. 2017). 
6.2 STUDY II: FACTORS ASSOCIATED WITH BLOOD 
CULTURE POSITIVITY IN PATIENTS WITH CSSSI
Blood cultures were positive in 23.6% of patients from whom blood was 
sampled. This percentage is higher than in most studies. A similar observational 
multi-center study from Central and Southern Europe including also patients 
with cSSSI observed a blood culture positivity of 12% of those who had blood 
cultures performed with similar blood culturing rate of 53% as in our study 
(Garau et al. 2013). A study including 334 hospitalized patients with skin and 
soft-tissue infection found bacteremia in 16% of patients from whom blood was 
cultured (52%; van Daalen et al. 2017). 
Most common blood culture isolates were Streptococcus pyogenes and 
Staphylococcus aureus with equal shares (n=19, 31%). Non-A beta-hemolytic 
streptococci were found in 20% (n=12) and gram-negative bacteria only in one 
case. These findings differ from the study by van Daalen and colleagues who 
found more gram-negative bacteria than Staphylococcus aureus and Peralta 
and colleagues who found a gram-negative etiology in one-fourth of bacteremias 
(Peralta et al. 2006, van Daalen et. al 2017). Differences might be explained by 
differences in patient selection. In addition, in a study by Peralta et al. blood 
culture sampling rate was only 14% indicating probably that blood culturing 
were performed in more severe cases (positivity rate was 19%; Peralta et al. 
2006). Similar predominance of beta-hemolytic streptococci and S. aureus has 
been observed in observational study including cSSSI (Jenkins et al. 2010). In 
abovementioned large study including patients with cSSSI 40% of all blood 
culture isolates were S. aureus, but only 22% were beta-hemolytic streptococci 
(Garau et al. 2013), whereas in our study corresponding percentages were 31% 
and 51%. 
Factors found to be associated with increased blood culturing were diabetes, 
symptom duration shorter than two days and CRP measure over 150 mg/L at 
the time of the diagnosis. CRP over 150 mg/L was found to be associated with 
increased blood sampling rate in multivariate analysis and CRP measured at 
time of the diagnosis was significantly higher in patients from whom blood was 
cultured (median 181 mg/L) compared to those not subjected to blood culture 
sampling (median 130 mg, P=0.003). Similarly, in a study including 476 
patients with uncomplicated cellulitis higher CRP was linked to more blood 
culturing (77 mg/L vs 119 mg/L, P<0.001; Bauer et al. 2016) and in another 
study including patients with erysipelas mean CRP was 91 mg/L for those who 
had blood cultured compared to 57 mg/L for those who did not (Bläckberg et al. 
2015). Eventhough higher CRP seemed to encourage clinicians to order blood 
cultures, it was not associated with blood culture positivity in multivariate 
analysis in our study. In a study by Bauer and colleagues CRP was significantly 
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higher in bacteremic patients (187 mg/L) than in non-bacteremic patients (116 
mg/L, P=0.02) in univariate analysis, but this result did not persist in 
multivariable analysis (Bauer et al. 2016). In addition, another study also found 
diabetes to be associated with increased blood culturing in patients with 
erysipelas (Bläckberg et. al 2015). Of note, Bauer and colleagues and Peralta and 
colleagues used multivariate analysis in their study, but Bläckberg and 
colleagues did not. 
In multivariate analysis only alcohol abuse was found to be significantly 
associated with blood culture positivity, as 54% of patients with a history of 
alcohol abuse had positive blood cultures compared to 20% of those who did 
not. Similarly, alcohol abuse was the only discriminant patient characteristic 
linked to bacteremia in patients with uncomplicated cellulitis (Bauer et al. 
2016). 
Interestingly, prior antibiotic treatment was not negatively associated with 
blood culture positivity in our study, which is in contrast to one previous study 
(Peralta et al. 2006). However, prior antibiotic treatment discouraged clinicians 
from ordering blood cultures as patients with antibiotic treatment before the 
diagnosis of cSSSI had blood culture taken in 45% of cases compared to 55% 
who did not (P=0.004). These factors did not remain significant in multivariate 
analysis models. In any case, knowledge of prior or ongoing antibiotic treatment 
alone should not discourage clinicians from ordering blood cultures. 
Patients with cellulitis/fasciitis (i.e., no abscess or ulcer present) were more 
likely to have blood cultured compared to other patients (66% vs 23%). This 
difference was statistically significant in univariate analysis (P<0.001) and a 
strong trend was seen in multivariate analysis (OR 1.6, P=0.052). Accordingly, 
the opposite clinical conditions (i.e., by definitions used to define these 
conditions), such as an abscess, infected ulcer or post-surgical wound made 
sampling less likely (in univariate analysis). Clinicians, perhaps, evaluated 
microbial sampling from these foci to be sufficient in determining the etiology of 
infection. Also, patients with cellulitis/fasciitis were likely to be bacteremic and 
patients with an abscess less likely in univariate analysis, but in multivariate 
analysis significance of this difference was not confirmed. 
Patient´s severe co-morbidity (van Daalen et al. 2016) and presence of two 
or more co-morbid factors (Peralta et al. 2006) have been linked to bacteremia, 
but we could not confirm these findings.  
Patients with positive blood cultures had antibiotic treatment significantly 
more often streamlined compared to blood culture negative patients (23.3% vs 
6.3%, P<0.001). This is a clear benefit of blood culturing and challenges the 
finding from patients with uncomplicated cellulitis where blood culture 
positivity rarely affected antibiotic treatment (Paolo et al. 2013). In accordance 
to our results, in a study including 308 patients with lower limb cellulitis, a 
change in the antibiotic therapy was noted in 49% of patients after blood culture 
results (Peralta et al. 2006).  
In our study, bacteremia was linked to later clinical stability, which without 
the information from blood cultures might lead to a premature change of 
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antibiotic treatment to more broad-spectrum. Furthermore, one-third of blood 
culture isolates were S. aureus, which is a clinically important finding for it 
warrants prolonged antibiotic treatment, and search for deep foci such as 
endocarditis (Thwaites et al. 2011). In conclusion, several benefits of 
information gathered from positive blood cultures could be demonstrated in this 
study. The importance of blood culture-directed therapy in countries with 
higher antibiotic resistance has also been pointed out (Eron and Lipsky 2006). 
The strengths of this study derive from its population-based nature. 
Although, some patients may have been left unrecognized due to coding 
inexactness. Limitation of this study is its retrospective nature and missing data 
in some variables. In addition, 56% of patients were subjected to blood culturing 
causing selection bias. Previous analysis of this patient material showed an 
association between blood culture draw and higher mortality, and this probably 
indicates that clinicians ordered blood culturing from sicker patients 
(Jääskeläinen et al. 2016). Despite difference in blood culture drawing rates 
between the two centers, the positivity rate was similar, suggesting that in 
patients with cSSSI blood culturing should be done with low threshold. 
6.3 STUDY III: IMPACT OF PRE-OPERATIVE ANTIBIOTIC 
TREATMENT ON MICROBIAL FINDINGS FROM 
RESECTED ENDOCARDIAL MATERIAL
In our study all valve cultures were negative in patients who received more than 
two weeks of effective antibiotic treatment before surgery. Similarly, mean 
duration of effective pre-operative antibiotic treatment of 4 days (range 2-8 
days) for those who had valve cultures positive was observed (Kotilainen et al. 
2006). In another study, sensitivity of valve PCR and valve culture were similar 
in detecting the causative organisms if pre-operative antibiotic treatment was 
less than 5 days, but after that sensitivity of valve culture dropped markedly but 
PCR did not (Voldstedlund et al. 2008). In accordance, in a study of 
streptococcal IE, all but one valve culture were negative after two weeks of 
antibiotic therapy (Upton et al. 2005). One study did not find negative effect of 
pre-operative antibiotic treatment duration on valve culture yield (Peeters et al. 
2017). A quite high number of false-positive valve cultures have been reported in 
some studies raising a concern of their utility (Liesman et al. 2017). Alleviating 
this concern, in the present study only two valve cultures were ruled as 
contaminants. 
In this study we demonstrated a negative impact of the duration of the pre-
operative antibiotic treatment on the positivity of valve PCR. Patients with pre-
operative duration of antibiotic therapy shorter than two weeks had PCR 
positive in 91% of cases and after two weeks the positivity dropped markedly to 
53% (P<0.001). In addition, a significant difference in the median durations was 
observed between PCR positive and negative cases (8.5 days vs 24 days, 
P=0.001). Other studies have been unable to demonstrate a similar effect 
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(Rovery et al. 2005, Kotilainen et al. 2006, Voldstedlund et al. 2008, Peeters et 
al. 2017). The mean duration of preoperative antibiotic treatment was 19.6 days 
(range 1-58) for patients who had PCR-positivity compared to 22.6 days (range 
0-60 days) who had valve PCR-negative (P=0.65) in study from South-western 
Finland (Kotilainen et al. 2006). Voldstedlund et al. observed no significant 
difference in the median duration of pre-operative antibiotic treatment in PCR-
positive and PCR-negative cases (Voldstedlund et al. 2008). In a study of 126 
patients operated during active IE the median duration of 19.5 days of 
antimicrobial treatment (range 1-150) for patients with negative PCR and 14 
days (range 1-79) for patients with positive PCR (P=0.28) was observed (Rovery 
et al. 2005). Also, the proportion of PCR positivity in patients with antibiotic 
treatment for 15 days or less was 66% and for those over 15 days (55%, P=0.19).  
It is noteworthy that after four weeks of effective therapy nearly half of the 
patients still had PCR test positive. In one patient PCR was positive after six 
months of initial IE episode caused by Granulicatella adiacens. At the time of 
the surgery the patient was still receiving oral antibiotic due to concomitant 
spondylodiscitis. After operation the antibiotic was stopped and no relapse 
occurred. Similarly, one patient from the patient cohort of study IV had PCR 
positivity (E. faecalis) 18 months after treatment of IE without signs of active IE 
and no relapse occurred eventhough antibiotic treatment was discontinued after 
surgery. These findings point out that bacterial DNA may persist for long period 
in heart valves and cannot be used as a guide for therapy. This was further 
demonstrated in the abovementioned study in which patients with active 
treatment for endocarditis had valve PCR positivity in 60% (76 out of 126) of 
cases whereas patients who had completed the antibiotic course for IE at time of 
surgery had PCR positivity in 37% (11/30) of cases, P=0.02 (Rovery et al. 2005). 
Median time for PCR positivity in latter group (i.e., 11/30) was 167 (range 45 – 
2,920 days). Also, they found that PCR was positive significantly more often if 
histological signs of IE were present and also if Gram staining was positive. 
In conclusion, the meaning of persistence of bacterial DNA for considerable 
long time after successful treatment is uncertain. Interestingly, this applies also 
to Gram staining, which may remain positive also for longer time and is found 
positive also in patients with treated IE and sterile valve cultures and negative 
histopathology (Morris et al. 2003). 
The diagnostic value of the PCR have been shown in several studies, 
especially in cases of blood culture-negative IE (Vondracek et al. 2011, Miller et 
al. 2016). Our results add to weight of this evidence as we showed the diagnostic 
impact of PCR in 14% of cases. This is in agreement with a study from France in 
which PCR contributed to the microbiological etiology in one-fifth of IE patients 
(Gauduchon et al. 2003). A study from Canada of 68 IE patients showed even 
higher contribution of PCR method (in 31% of cases) and it made a contribution 
to the clinical decision in 13% of cases (Miller et al. 2016). 
 In the studies III and IV we describe nine cases of IE caused by Bartonella 
quintana, two cases 0f IE caused by Coxiella burnetii and two cases of IE caused 
by Tropheryma whipplei. First case of IE caused by Bartonella quintana in 
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Finland was reported from South-western Finland (Jalava et al. 1995). This case 
was included in their study from 2006 including a total 56 cases of operatively 
treated IE (Kotilainen et al. 2006). However, no other B. quintana IE cases were 
found. In studies from Sweden and Denmark including patients with IE 
undergoing surgery and molecular methods applied, no IE cases caused by 
Bartonella spp. were found (Voldstedlund et al. 2008, Vondracek et al. 2011). 
Also, in a prospective study of 334 IE cases from western Sweden, serological 
findings for B. quintana or C. burnetii were rare (Werner et al. 2003). In a 
multinational IE study, however, most cases of these two infections came from 
Europe (Murdoch et al. 2009). These observations highlight the geographical 
variation of causative agents of IE and the importance of population-based 
studies from different parts of the world.  
In the present study, one-third of Bartonella IE cases had IE-associated 
glomerulonephritis, a finding which is suggested also in previous literature 
(Khalighi et al. 2014). Two cases were also blood culture positive. In both cases 
laboratory had prior information of the suspicion, which probably enabled the 
finding. This underlines the importance of collaboration between clinicians and 
microbiologists. 
Seeing that IE is relatively rare condition and surgery is required in one-third 
to one-half of the cases, the 87 patients included in our study make it one of the 
largest of its kind. However, 22 patients were excluded because operating 
surgeon did not obtain a sample for PCR, so selection bias might exist. On the 
other hand, 12 of these occurred during the first year of study and then 1-3 cases 
annually, so the most likely explanation is that surgeons had yet not adopted a 
new protocol, rather than other systematic bias. Samples for PCR were not 
standardized. Operating surgeons obtained the sample from the sites most 
clearly infected in the visual and manual inspection of the valve.   
6.4 STUDY IV: THREE DIFFERENT CLINICAL ENTITIES OF 
INFECTIVE ENDOCARDITIS 
In the patient cohort, CAIE, HAIE and IDUIE were observed in almost equal 
proportions, each accounting for approximately one-third of the cases.  
During the study period 2013-2017 the incidence was 6.48/100,000 person-
years. No significant change in incidence between the study years was observed. 
The observed incidence is in line with a recent population-based registry study 
from entire country of Finland, which reported annual occurrence rate of IE 
admissions to be 6.33 per 100,000 person-years (Ahtela et al. 2019). Incidence 
rates in person-years according to the mode of acquisition per 100,000 were: 
2.46 for CAIE, 2.01 for HAIE and 2.01 for IDUIE. No significant change in these 
incidence rates by mode of acquisition during the study period was observed 
either. Rates for these different entities have rarely been reported. A population-
based study from Australia reported an annual incidence of HAIE to be 
1.5/100,000 (Sy and Kritharaides 2010). However, the definition of HAIE used 
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in the Australian study is narrower than commonly used, thus probably 
underestimating the true incidence. 
The present study confirms the emergence and major proportion of HAIE. In 
the whole study cohort one-third and in non-PWID nearly one-half of IE 
episodes were HAIE. In a population-based study from France one-quarter of all 
IE episodes were HAIE (Selton-Suty et al. 2012) and in a large multinational 
study excluding PWID and PVE (Benito et al. 2009) the proportion of HAIE was 
approximately one-third, which are smaller proportions compared to our 
material. In a more recent population-based study from USA (States of New 
York and California) one-half of IE cases were HAIE (Toyoda et al. 2017). 
Together with our observation, this highlights the increasing significance of 
HAIE. 
In comparison of CAIE to HAIE the present study describes distinct features: 
patients with CAIE had less frequently diabetes, chronic kidney disease and 
immunosuppressive therapy and Enterococcus spp. responsible for IE and more 
frequently viridans group streptococci as causative agent than patients with 
HAIE. The observation of higher comorbidity in HAIE has also been made in a 
population-based study from Australia (Sy and Kiritharides 2010) and in two 
studies from Spain (Fernandez-Hidalgo et al. 2008, Lomas et al. 2010). These 
three studies have also found patients with HAIE to be older compared to CAIE, 
but we could not confirm this finding. 
IDUIE accounted for one-third of the cases. This proportion is quite large 
compared to other studies (Slipczuk et al. 2013). Although, a study from 
Kentucky, USA, where the opioid epidemic is prevalent, reported an IDUIE 
proportion of 40% (Seratnahaei et al. 2014) and a study from Western Norway 
reported a proportion of 23.5% (Jordal et al. 2018). Both these two studies 
noted also an increase in IDUIE during their study periods. An increase in 
IDUIE was also noted in a national register study from USA (Rudasill et al. 
2019). These studies highlight the growing importance of IDUIE due to 
increasing drug abuse in many western countries. However, population-based 
registry study from Spain reported proportions of less than 5% during the study 
period 2003-2014 with decreasing numbers (Olmos et al. 2017) and a 
population-based study from France reported 5.8% share of IDUIE (Selton-Suty 
et al 2012). These studies demonstrate the geographical variation in proportions 
of IDUIE of all IE cases and point out the need to be cautious when 
extrapolating data on IDUIE from different regions. Drug abuse predisposing to 
IE may be higher in our study´s region compared to many other regions. 
Approximately one-third of Finnish problem drug users (i.e., abusers of 
methamphetamine and opioids) reside in the study area and in 2012 there were 
an estimated 5,600-10,300 problem users in the study area (representing 
0.73%-1.34% of the population aged between 15 and 65; Varjonen 2015). Also, 
incidence of drug abuse in Finland is increasing (Kankaanpää et al. 2016). 
Altogether, our finding of IDUIE accounting for one-third of the IE episodes, an 
equal share compared to HAIE, is one of the key findings in this study and 
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indicates that in areas where drug use is common concomitant IDUIE 
contributes to a large part of all episodes of IE. 
Studies comparing features of IDUIE to other community-acquired IEs are 
very rare and most studies compare IDUIE to non-IDUIE in which case the non-
IDUIE group also includes those with health care-association. In our material, 
patients in CAIE group were older with higher comorbidity and proportion of 
males than in IDUIE. Also, left-sided IE and viridans group streptococci as 
etiology were more frequent in CAIE than IDUIE. Whereas, in CAIE both-sided 
infection, a history of previous IE and S. aureus as etiology was less frequent. A 
recent study comparing IDUIE to non-IDUE found similar differences as we 
describe, although in IDUIE group itself left-sided IE occurred more frequently 
compared to right-sided (45% vs 35%) which differs from our material (Leahey 
et al. 2019). A study describing a cohort of 202 IEs in PWID described 
characteristics very similar to ours: median age of 34, right-sided infection in 
64% and S. aureus being responsible for 77% of cases (Rodger et al. 2018). 
Results of this study confirm the role of S. aureus as a leading pathogen 
causing IE in a population level. In whole study group S. aureus constituted 
one-third of the cases, followed by viridans group streptococci (21.4%) and 
enterococci (9.9%). Similar proportions are reported from other studies 
(Murdoch et al. 2009, Selton-Suty et al. 2012). Some studies have noted an 
increase in enterococcal IE and with proportions higher than ours, 13%-16% 
(Jordal et. al 2018, Habib et al. 2019). 
Approximately in one-sixth of the IE cases cerebral complication occurred.  
Septic emboli to other sites occurred in half of the cases, and less frequently in 
CAIE compared to IDUIE. This is probably to do with more S. aureus IE in 
IDUIE.  
Overall, 23% of patients needed operative treatment. This is in line with 
other population-based studies (Sy and Kritharides 2010, DeSimone et al. 2015, 
Toyoda et al. 2017). Higher surgery rates are reported from referral centre-
based studies (DeSimone et al. 2015, Olmos et al. 2017). CAIE cases were 
operated more frequently than patients with IDUIE, probably due to left-sided 
dominance of location of IE in CAIE. 
We report in-hospital mortality rate of 17%. Most population-based studies 
report similar rates (Selton-Suty et al. 2012, Keller et al. 2017). Both in-hospital 
mortality and one-year mortality were lower in CAIE compared to HAIE (15% vs 
28% and 19% vs 43%, respectively). Similar observations of higher mortality in 
HAIE have been made in previous studies as well and they have found HAIE to 
be an independent risk factor for death (Fernandez-Hidalgo et al. 2008, Lomas 
et al. 2010). Lower mortality-risk in patients with IDUIE compared to non-
IDUIE was observed in a large registry-base study from USA (Rudasill et al. 
2019), but in our study we found no statistical difference (9% vs 15%, P=0.200). 
The trend toward lower mortality in IDUIE compared to CAIE is, however, 
observed and lack of statistical significance is probably due to low total numbers 
of cases. Interesting observation is the increase in mortality in IDUIE group 
when comparing in-hospital mortality to one-year mortality (from 9.3% to 
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17.5%) while similar change is not seen in CAIE (from 15% to 19%). Given the 
younger age, lower co-morbidity and more frequent right-sided location (i.e., all 
factors associated with better come) in IDUIE, the increase in mortality is 
therefore probably explained by some other factor. The most plausible being 
continuing drug abuse, which highlights the importance of concomitant 
addiction treatment. Addiction treatment has been noted to impact better 
outcome (Rodger et. 2018). 
The major strength of this study is its population-based nature. Most data on 
IE are derived from patients treated in referral centrals (Slipczuk et al. 2013). 
This introduces a selection bias towards more complicated cases (Kanafani et al. 
2010). We decided to categorize IE according to the mode of acquisition for 
following reasons: 1) to determine their proportions and incidence and 2) to 
describe their unique features and differences. IDUIE is a well-known distinct 
clinical entity of IE and IDU is a strong risk factor for IE (Moss and Munt 2003), 
so IDUIE was reasonable to consider as its own entity. Moreover, health care-
association in IDUIE cases is rare (Asgeirsson et. al 2016, Rodger et al. 2018). 
Another strength of this study is complete information on microbiology and very 
few missing data. In addition, an infectious disease specialist (M.H.) collected 
and reviewed all data. 
Limitations derive from the retrospective nature of the study. Data on patient 
history before hospitalization were retrieved from medical patient records thus 
the accuracy of the data rely on the notes of the treating physicians. Patients 
were recognized using ICD-10 codes, so some cases may have been left out due 
to coding inaccuracy. If a patient had moved outside the study region during the 
following year the follow-up data might be inaccurate. Findings of this 
population-based study might not be generalizable outside the study population. 
6.5 FUTURE CONSIDERATIONS
The benefit of new microbial methods should be examined also from the clinical 
standpoint. The impact of MALDI-TOF on the treatment and outcome in 
patients with BSI is well studied, but further studies are needed. Our study 
showed that even when introduced into a routine clinical setting si-MALDI-TOF 
had a positive impact on the treatment of selected BSIs. However, MALDI-TOF 
is probably even more powerful if combined with ASP intervention, i.e., in the 
hands of experts who are capable of fully exploiting the provided new 
information. The lack of ASP probably explains why si-MALDI-TOF did not 
provide additional impact in case of AmpC-producing Enterobacteriaecae BSI. 
In addition to ASP intervention, electronic reminders and antibiotic guidelines 
might help to fully exploit the benefits of the new rapid diagnostic methods. The 
impact and cost-effectiveness of MALDI-TOF alone versus in combination with 
ASP should be further studied. Various rapid diagnostic tests, including MALDI-
TOF, are being developed and studied to target also the possible resistance of 
the bacteria causing BSI and their clinical impact should be studied from 
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clinicians’ perspective. However, currently and in the near future these will only 
be supplementary to conventional blood cultures. 
Only few studies exist to study the impact of pre-operative antimicrobial 
treatment duration on the yield of microbial samples obtained during heart 
surgery in patients with IE. This should be further studied. If the yield of PCR 
method is confirmed to diminish with prolonged treatment that would in blood 
culture negative patients even advocate earlier timing of surgery. The cost-
effectiveness of the PCR method routinely obtained from patients with IE is 
undetermined and should be examined. The data from our, and other studies as 
well, strongly support the usefulness of routine valve PCR in surgery performed 
for IE.  
In case of SSSI, when should a clinician order blood culturing? Based on our 
study, in case of cSSSI even a routine blood culture sampling might be feasible 
for the following reasons: 1) the high blood culture positivity rate, 2) benefit of 
the information gained from positive blood cultures, and 3) practical difficulties 
with prediction scores. At least in alcoholics with cSSSI blood culturing 
routinely is feasible. Other risk groups need further defining. Additionally, 
factors associated with bacteremia in different entities of SSSI deserve further 
study. The cost benefit of blood culture sampling in patients with cSSSI remains 
undefined and should be studied. 
Infective endocarditis is a challenge for clinicians. Given the evolving nature 
of IE, repeated studies on its epidemiology and microbial etiology are 
warranted. The ageing population in developed countries underlines this need. 
The modified Duke criteria have been widely used since their introduction 
twenty years ago. Uniform criteria are necessary in studies of IE. However, they 
should be modified again. ESC has proposed other imaging studies to be added 
along with cardiac echocardiogram to improve sensitivity and specificity. A 
recent large multinational study (EURO-ENDO study) used these new criteria. 
Also, PCR from valve samples should be added to the diagnostic criteria of IE. 
As HAIE is a growing and challenging entity of IE, generally accepted definition 
of HAIE is called for. Prevention of IE is its best treatment and this warrants 
further studies, given the emerging and challenging entities of HAIE and IDUIE. 
As HAIE is often a result of bacteremia associated with health-care procedures, 
especially intravascular catheter use, all effort should be made to reduce the risk 













Following conclusions can be drawn from the results of the studies: 
 
Study I
This study demonstrated that implementation of si-MALDI-TOF method into a 
routine clinical setting had a favourable impact on the empiric antibiotic 
treatment of selected BSIs. A significant benefit was demonstrated in patients 
with enterococcal BSIs.  
 
Study II
A population-based study including patients with cSSSI found that none of the 
factors associated with blood culture sampling were associated with blood 
culture positivity. Alcohol abuse was the only discriminant patient characteristic 
associated with blood culture positivity. Given the high proportion of bacteremic 
patients with cSSSI and the demonstrated clear benefit of information acquired 
from blood cultures, we recommend that clinicians should order blood cultures 
in this scenario with low threshold. 
 
Study III
In a large cohort of operatively treated patients with IE we found that pre-
operative antibiotic treatment decreased the diagnostic yield of microbiological 
samples obtained from resected endocardial material. All valve cultures were 
negative in patients who had received pre-operative antimicrobial treatment for 
more than two weeks. PCR positivity also dropped from 91% to 60% after two 
weeks of antimicrobial treatment, but remained approximately in 50% after four 
weeks of treatment. PCR from resected endocardial material had a diagnostic 
impact in one-sixth of the cases in whole study cohort and it was especially 
useful if blood cultures were negative. 
 
Study IV
The present population-based study was the first to explore the incidence, 
characteristics, microbial etiology and outcome of IE in the Helsinki University 
Hospital area. The study described IE incidence of 6.48 per 100,000 person-
years in adults in the study area. Almost equal shares of CAIE, HAIE, and 
IDUIE were observed and their distinct clinical features and outcome were 
described. In areas where drug use is common, concomitant IDUIE seems to 
constitute to a major part of all IE episodes, and even with an equal share than 
HAIE. These two entities also differ from CAIE. Findings of this study are of 
benefit to physicians treating the challenging entity of IE and suggest that in 
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